Your browser is no longer supported. Please, upgrade your browser.
IWM iShares Russell 2000 daily Stock Chart
iShares Russell 2000
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.42%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.03%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter13.15%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.18 Perf Half Y14.62%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year35.96%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range92.21 - 138.25 Perf YTD1.05%
Dividend1.88 P/FCF- EPS past 5Y- ROI- 52W High-1.44% Beta-
Dividend %1.38% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low47.77% ATR1.76
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)55.40 Volatility1.21% 1.23%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.85 Prev Close135.28
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume32.84M Price136.26
Recom- SMA200.31% SMA503.71% SMA20013.19% Volume27,106,900 Change0.72%
Jan-16-17 11:15AM  Mario Gabelli Says Capitalism, Innovation, and Law Drive the US
07:36AM  Goldman Sachs: Is Strong Dollar Creating Investment Opportunities?
Jan-14-17 11:36AM  The Week Ahead: Will The Market Trump Skeptics at Forbes
09:38AM  Barron's Experts: 8 Picks For a Topsy-Turvy Year at
08:00AM  What to expect from the stock market this week
Jan-13-17 04:52PM  Stocks Mixed as Trump Rally Flounders (SPY, DIA) at Investopedia
11:49AM  Shark Bites: Shippers Teekay and Diana Are Fun Trading Vessels
10:39AM  Will Wage Growth Continue to Support US Economy?
09:30AM  Zacks Investment Ideas feature highlights: Amazon, Exxon, Qualcomm, S&P 500 and Russell 2000 small cap ETF
Jan-12-17 05:44PM  Will Generation X Finally Cash in On Stocks?
01:56PM  Rooting for Some Deeper Pullbacks To Add Names I Like
11:31AM  No-Commission ETFs: More Volume, Tighter Spreads
09:07AM  ADP Report Highlights: Were 153,000 New Jobs in December Enough?
Jan-11-17 02:05PM  Why the Canada Manufacturing PMI Improved in December
12:35PM  December Manufacturing PMI: Is US Business Condition Improving?
12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes
12:26PM  Charts Talk In Spite Of Market's Nervousness at Forbes
10:49AM  ETF Bubble or No Bubble? at Investopedia
07:44AM  Small Business Owners Are Downright Giddy; Here's How to Profit
Jan-10-17 01:38PM  Still Struggling to Put Money to Work
12:30PM  Charting a slow-motion breakout attempt: Dow back for another crack at 20,000 at MarketWatch
10:22AM  5 U.S. Equity ETFs Beginning 2017 with a Bang
07:37AM  Marc Lasrys Optimistic View on Trumps Cabinet Selections
07:00AM  Trader's Daily Notebook: Bulls Won't Rest Easy
Jan-09-17 05:10PM  Short Interest in Flotek Is Increasing: What Does That Mean?
04:23PM  Stock Market Video Analysis 1/9/17
11:35AM  Marc Lasry: Market Is Going to Get More Expensive
09:55AM  Marc Lasry: Market Might See a 10% Rally in 2017
09:13AM  A Few Trade Ideas Ahead of Dow 20,000
07:23AM  Rev's Forum: This Market Favors Big Picture Market Timers
07:00AM  Trader's Daily Notebook: I'd Rather Sport the Rose-Colored Glasses for Now
Jan-07-17 01:55PM  The Week Ahead: Who Is The Bears Best Friend? at Forbes
08:00AM  What to expect from the stock market this week
Jan-06-17 05:56PM  Stocks Begin the Year on a High Note at Investopedia
04:51PM  The Math Professor Who Beat Las Vegas And Wall Street at Forbes
04:25PM  Stock Indices' Strong Closings Mask Underlying Weakness
Jan-05-17 06:05PM  UBS: Dont Panic Is the Biggest Lesson of 2016
04:51PM  3 ideas to improve waiting for your trades
04:35PM  Fox Businesss Outlook for the US Economy in 2017
02:45PM  With Rising Rates, Is It a Bullish Or Bearish Outlook For Small Cap ETFs?
11:13AM  #1 issue top traders want to fix in 2017 on our prop desk
07:35AM  Will the Dollar Provide a Big Investment Opportunity in 2017?
Jan-04-17 12:04PM  Analyzing How the Yield Curve Impacts Small Caps
12:04PM  How Would Higher Inflation Impact Small Caps?
12:04PM  Why Did Small-Cap Stocks Have a Stellar Year in 2016?
10:36AM  Trumps Win Could Create Growth in the Technology Sector in 2017
10:11AM  2016 Price Ranges Were Spot On, What About 2017? at Forbes
07:58AM  My Favorite Hedge Fund Story Of 2016 at Forbes
07:00AM  6 Traits of the Best Indexes at Morningstar
04:35AM  How much money you could have made (or lost) with these bold market bets at MarketWatch
Jan-03-17 09:03PM  Trump's Plan Is A Recipe For Restoring Animal Spirits at Forbes
02:35PM  How Did the Technology Sector Perform in 2016?
02:05PM  Oil, Biotechs, Nvidia, Apple Weigh on Markets
01:51PM  Bull trend pauses: Charting the S&P 500s early-2017 holding pattern at MarketWatch
01:05PM  Will the S&P 500 Index Continue Its Rally in 2017?
11:23AM  How Did the S&P 500 Index Perform in 2016?
11:18AM  Top Large-Cap, Small-Cap And Midcap ETFs Of 2016: Focus On Dividends
10:12AM  Market Scorecard: 2017 Begins With Technical Warnings
Dec-31-16 12:13PM  The Week Ahead: The 2014 Bubble That Is Still Deflating at Forbes
08:00AM  What to expect from the stock market this week
Dec-30-16 04:57PM  Stocks End a Bullish Year on a Low Note (SPY, DIA) at Investopedia
04:48PM  Stock Market Video Analysis 12/30/16
04:23PM  Here are the biggest ETF winners and losers of 2016 at MarketWatch
11:46AM  What Does 2017 Have in Store? 3 Market Metrics That Will Tell You
11:08AM  This is why stocks look set to fall as 2017 arrives at MarketWatch
07:37AM  Whats Carl Icahns View on Chinas Trade Policy?
Dec-29-16 09:08AM  Carl Icahn: Dangerous Amount of Money Blocked in ETFs
08:47AM  Things to Watch for in the Russell 2000
08:02AM  Beware Pension Fund Re-Balancing Into Year-End at Forbes
Dec-27-16 03:05PM  Nasdaq CEO on Technology: Trumps Policies Could Create Growth
12:35PM  US Consumer Sentiment Index Rose: What It Means for the Economy
09:19AM  U.S. Market ETFs Take a Breather for Last Week of 2016
07:35AM  Short Interest in Flotek Falling: What Does It Mean?
Dec-26-16 10:35AM  Valuation: Flotek Industries versus Peers
Dec-24-16 12:41PM  The Week Ahead: Beware The Holiday Hangover at Forbes
08:01AM  What to expect from the stock market this week
Dec-23-16 09:00PM  Icahn Almost Right About ETFs; The Long and Short of Apple, J.C. Penney: Best of Kass
05:43PM  U.S. Markets Largely Unchanged Before Holidays at Investopedia
12:32PM  The Best Investing Podcasts for 2017
10:33AM  Here's How Hedge Funds Positioned Themselves In Q4 at
08:47AM  Why Is Energy Important to Wall Street?
07:00AM  Trader's Daily Notebook: Wake Up and Sell the Small-Caps
Dec-22-16 04:44PM  Market Action Is Worse Than It Looks
04:35PM  Will All of the Sectors Get Equal Opportunities under Trump?
01:15PM  4 reasons to weight your portfolio toward small-cap growth stocks in 2017 at MarketWatch
07:36AM  Which Economic Indicators Should Investors Watch This Week?
Dec-21-16 02:05PM  US Inflation Meets Expectations: Is the Economy Improving?
12:35PM  US Industrial Production Fell: What It Means for the Economy
10:49AM  US Retail Sales Showed Weaker Improvement in November
09:08AM  2017 Is The Year Of The Active Manager at Forbes
09:05AM  Understanding Horizon Pharmas Revenue Growth beyond 2016
08:48AM  Why Is Whitney Tilson Skeptical about the Trump Rally?
Dec-20-16 06:57PM  Chip ETF Sizzles Amid Nvidia, AMD Upgrades; Gold Resumes Its Plunge
03:08PM  Five reasons stocks are being bought and gold sold despite terror news at MarketWatch
09:07AM  Sidoti Upgrades Sanderson Farms to Buy
09:07AM  The US Dollar Is Strengthening: How Will It Impact the Economy?
Dec-19-16 05:56PM  Don't bet on Trump rally ending in the new year, expert says at CNBC
09:38AM  Market ETF Scorecard: Go for Diamonds, Spiders and QQQs
09:07AM  How Did Sanderson Farms Perform in 4Q16?
Dec-17-16 12:52PM  The Week Ahead: How High Can The Market Forecasts Go? at Forbes
The investment seeks to track the investment results of the Russell 2000 Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
DHR Danaher Corporation daily Stock Chart
Danaher Corporation
IndexS&P 500 P/E26.57 EPS (ttm)3.06 Insider Own0.20% Shs Outstand691.11M Perf Week1.16%
Market Cap56.23B Forward P/E20.70 EPS next Y3.93 Insider Trans-11.44% Shs Float606.17M Perf Month2.84%
Income2.14B PEG4.09 EPS next Q1.03 Inst Own77.40% Short Float1.44% Perf Quarter6.93%
Sales18.18B P/S3.09 EPS this Y3.30% Inst Trans0.12% Short Ratio2.59 Perf Half Y0.87%
Book/sh33.50 P/B2.43 EPS next Y10.24% ROA5.40% Target Price89.72 Perf Year23.71%
Cash/sh1.41 P/C57.88 EPS next 5Y6.50% ROE10.60% 52W Range61.20 - 82.38 Perf YTD4.52%
Dividend0.50 P/FCF21.09 EPS past 5Y7.70% ROI7.30% 52W High-1.23% Beta1.00
Dividend %0.61% Quick Ratio1.00 Sales past 5Y10.40% Gross Margin54.20% 52W Low32.94% ATR0.88
Employees81000 Current Ratio1.40 Sales Q/Q17.60% Oper. Margin15.00% RSI (14)66.98 Volatility0.94% 1.07%
OptionableYes Debt/Eq0.36 EPS Q/Q5.60% Profit Margin14.10% Rel Volume0.71 Prev Close81.29
ShortableYes LT Debt/Eq0.32 EarningsJan 31 BMO Payout16.30% Avg Volume3.36M Price81.36
Recom1.70 SMA202.63% SMA503.33% SMA2005.36% Volume2,395,100 Change0.09%
Dec-13-16Resumed Morgan Stanley Overweight
Jul-11-16Reiterated Barclays Overweight $105 → $86
Jul-05-16Initiated Goldman Neutral
Jun-24-16Upgrade Bernstein Mkt Perform → Outperform
May-27-16Reiterated RBC Capital Mkts Sector Perform $96 → $99
Apr-22-16Reiterated Stifel Buy $109 → $110
Apr-22-16Reiterated RBC Capital Mkts Sector Perform $87 → $96
Apr-22-16Reiterated Barclays Overweight $104 → $105
Apr-18-16Reiterated Barclays Overweight $99 → $104
Apr-04-16Downgrade Bernstein Outperform → Mkt Perform
Jan-27-16Reiterated RBC Capital Mkts Sector Perform $93 → $87
Dec-08-15Downgrade Goldman Buy → Neutral
Oct-26-15Reiterated Argus Buy $98 → $104
Oct-23-15Reiterated Stifel Buy $98 → $103
Oct-23-15Reiterated RBC Capital Mkts Sector Perform $91 → $92
Oct-23-15Reiterated Barclays Overweight $89 → $94
Oct-01-15Reiterated Stifel Buy $100 → $98
Sep-30-15Initiated Leerink Partners Outperform
Sep-09-15Reiterated RBC Capital Mkts Sector Perform $93 → $91
Sep-09-15Initiated Sterne Agee CRT Neutral
Jan-11-17 04:15PM  Danaher Schedules Fourth Quarter 2016 Earnings Conference Call PR Newswire
Jan-10-17 08:02AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
Jan-04-17 04:15PM  Danaher To Present At J.P. Morgan Healthcare Conference PR Newswire
Jan-03-17 09:09AM  Danaher May Not Have Much More Growth in Store
09:07AM  Here's Why You Avoid Fortive Now
Dec-30-16 09:30AM  The Zacks Analyst Blog Highlights: Wells Fargo, Danaher, Colgate-Palmolive, STERIS and Aetna
Dec-27-16 01:22PM  Is Danaher Corporation Stock a Buy for 2017? at Motley Fool
Dec-26-16 07:37AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : December 26, 2016
Dec-15-16 11:37AM  Danaher Corp. Value Analysis (NYSE:DHR) : December 15, 2016
11:03AM  Danaher Does It at
06:00AM  Danaher Initiates 2017 Outlook PR Newswire
Dec-14-16 07:27AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : December 14, 2016
Dec-13-16 03:05PM  4 Industrial Stock Winners From Trump's Lower Taxes at
Dec-09-16 05:03PM  Ecolab Declares a Dividend of $0.37 per Share
Dec-08-16 08:39AM  Pantone hopes its color of the year will improve our gloomy mood
07:53AM  Will Danaher (DHR) Gain from Restructuring Initiatives?
Dec-06-16 04:55PM  DANAHER CORP /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Stat
04:15PM  Danaher Announces Quarterly Dividend PR Newswire
Dec-02-16 10:42AM  ETFs with exposure to Danaher Corp. : December 2, 2016
Dec-01-16 08:00AM  Danaher announces leadership appointment PR Newswire
07:38AM  Danaher Corp. breached its 50 day moving average in a Bearish Manner : DHR-US : December 1, 2016
07:32AM  GE Completes Strategic Divestiture of Interbanca Business
Nov-30-16 08:43AM  GE Poised on Strategic Organic Growth with Healthcare Focus
Nov-29-16 08:09AM  3M Company Trails Industry Performance Post 3Q Earnings
08:07AM  What Does Wall Street Expect from Donaldsons Fiscal 1Q17 Earnings?
07:38AM  Crane Fundamentally Strong, '16 View Solid: Time to Buy?
Nov-28-16 05:59PM  Final Trade: P, GDX & more
05:45PM  Is U.S. Bancorp (USB) a Good Stock To Buy? at Insider Monkey
04:41PM  GE to Strategically Expand Healthcare Portfolio at RSNA 2016
08:16AM  United Technologies Shows Promise with in Line Performance
Nov-27-16 09:02PM  Here is What Hedge Funds Think About Danaher Corporation (DHR) at Insider Monkey
Nov-24-16 08:31AM  Crane Hits New 52-Week High on Solid Performance & View
Nov-23-16 06:33AM  Compass Diversified Partially Divests Fox Factory Shares
Nov-22-16 04:58PM  Snap-on: Ratcheting Up Margins and Other Vital Metrics
09:30AM  The Zacks Analyst Blog Highlights: Coca-Cola, Disney, Danaher, Halliburton and Time Warner
07:52AM  GE Collaborates with Prysm to Enhance Digital Platform
Nov-21-16 12:44PM  Top Research Reports for 21st November, 2016
11:12AM  3M: Not Much To Gain From A Trump World at
07:28AM  Ingersoll (IR) Poised for Top-Line Growth, Risks Remain
Nov-17-16 11:09AM  A Closer Look At Tiger Legatus Capitals Top Moves: AMAYA (AYA), Danaher Corporation (DHR) & Others at Insider Monkey
Nov-16-16 10:21AM  Joel Greenblatt's Top 3 New Holdings for the 3rd Quarter
10:10AM  Merrill Lynch Makes 2 Huge New Additions to US 1 Stock List at 24/7 Wall St.
08:12AM  GE Solidifies Presence in Molecular Imaging with DILON Deal
Nov-15-16 06:03PM  [$$] Gap Names Former Kraft Finance Chief as Next CFO at The Wall Street Journal
09:14AM  United Technologies' Arm in Deal with Mexican VivaAerobus
07:34AM  GE Digital Buys ServiceMax to Augment Industrial Internet
Nov-14-16 04:15PM  Danaher To Webcast Investor And Analyst Meeting PR Newswire
11:52AM  3M & Danaher: Do Earnings Even Matter in Trump's Brave New World? at
Nov-10-16 07:37AM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events
Nov-04-16 07:20PM  Danaher Completes Acquisition Of Cepheid PR Newswire
Nov-03-16 07:18AM  UTX's Pratt & Whitney Consortium to Power A320ceo Aircraft
Nov-01-16 08:15AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : November 1, 2016
Oct-31-16 04:15PM  Danaher to Present at Baird Industrial Conference PR Newswire
Oct-28-16 08:15AM  Post Earnings Coverage as Danaher Q3 Earnings Shine on Acquisition Accesswire
Oct-25-16 04:13PM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obli
02:42PM  ETFs with exposure to Danaher Corp. : October 25, 2016
01:04PM  DANAHER CORP /DE/ Financials
11:05AM  Danaher Marginally Raises Its Fiscal 2016 Guidance on Better YTD Performance
10:56AM  3M (MMM) Marginally Beats Q3 Earnings, Trims 2016 Guidance
10:05AM  With Phenomenex, Danaher Has an Attractive Consumables Asset
08:05AM  Pall, High Growth Regions Take Danahers Sales Higher in 3Q16
Oct-24-16 05:03PM  Danaher Stock Jumps as EPS Grows 22.5% on Margin Expansion
10:00AM  Danaher Corp. :DHR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 24, 2016
Oct-21-16 06:15PM  Cramer: DHR and ITW have less in common than at first gla...
11:09AM  Earnings show signs of life
10:50AM  Honeywell (HON) Beats on Earnings in Q3, Tweaks Guidance
08:16AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : October 21, 2016
Oct-20-16 03:02PM  Edited Transcript of DHR earnings conference call or presentation 20-Oct-16 12:00pm GMT
10:33AM  Danaher (DHR) Q3 Earnings Top Estimates, Revenues Up Y/Y
09:16AM  Danaher (DHR) Stock Rises, Q3 Earnings Top Estimates
07:07AM  Q3 2016 Danaher Corp Earnings Release - 06:00 am ET
06:34AM  Danaher (DHR) Tops Q3 Earnings, Revenues Miss, Guides Up
06:14AM  Danaher beats 3Q profit forecasts
06:03AM  DANAHER CORP /DE/ Files SEC form 10-Q, Quarterly Report
06:02AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
06:00AM  Danaher Reports Third Quarter 2016 Results PR Newswire
Oct-19-16 03:05PM  What to Look for When Danaher (DHR) Reports Q3 Earnings
Oct-18-16 04:19PM  Will Earnings Streak Be Alive for Danaher (DHR) in Q3?
Oct-13-16 01:56PM  Newell Tools Says I Do to SWK after 14 Years
Oct-12-16 10:48PM  Scout Daily Update: JOLTS Weakens at Insider Monkey
02:39PM  [$$] Stanley Black & Decker: fully charged at Financial Times
10:37AM  Danaher Rises On 'Tuck-In' Acquisition at
03:30AM  Phenomenex to be Acquired by Danaher Corporation Business Wire
Oct-11-16 11:04AM  Why the Dental Segment Could Be a Growth Area for Danaher in China
10:06AM  Danaher Leads Healthcare Peers on YTD Returns
10:06AM  Why Danaher Is Relatively Immune from Growth Concerns in China
08:05AM  Danaher to Declare Its First Earnings after Fortive Separation
Oct-07-16 09:53AM  ETFs with exposure to Danaher Corp. : October 7, 2016
Oct-03-16 05:04PM  Which Idex Strategies Could Reduce the Effects of a Downturn?
01:03PM  Danaher Corp. : DHR-US: Dividend Analysis : September 30th, 2016 (record date) : By the numbers : October 3, 2016
Sep-30-16 04:40PM  Medical Device ETF Near Highs As Products, Equipment Groups Outperform
09:30AM  The Zacks Analyst Blog Highlights: BP, Berkshire Hathaway, Cognizant, eBay and Danaher
Sep-29-16 03:19PM  Top Research Reports for September 29, 2016
Sep-28-16 08:20AM  CLARCOR Increases Dividend by 14%, Shares Rise Marginally
Sep-26-16 01:34PM  Proxy Statement Shows Danaher Faced Competition In Bid To Buy Cepheid
Sep-20-16 04:15PM  Danaher Schedules Third Quarter 2016 Earnings Conference Call PR Newswire
Sep-19-16 08:27AM  [$$] Serial acquirers: fools not suffered at Financial Times
Sep-16-16 12:58PM  Why GenMark Diagnostics, Inc. Is Soaring Today at Motley Fool
Sep-13-16 04:15PM  Danaher Announces Quarterly Dividend PR Newswire
Sep-12-16 10:21AM  Cepheid (CPHD) Stock Downgraded to 'Neutral' at Baird at TheStreet
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Its Test & Measurement segment provides instruments products; services and products that help to convert concepts into finished products; professional tools; and wheel service equipment. The company's Environmental segment provides instrumentation and disinfection systems; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment system, environmental compliance, vehicle tracking, and fleet management. Its Life Sciences & Diagnostics segment offers chemistry systems, immunoassay systems, hematology and flow cytometry products, microbiology systems, and systems and workflow automations solutions. This segment also provides professional microscopes; mass spectrometers; bioanalytical measurement systems; workflow instruments and consumables; and filtration products, which are used to remove solid, liquid, and gaseous contaminants. The company's Dental segment offers consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. The company's Industrial Technologies segment provides equipment, consumables, and software for various printing, marking, coding, packaging, design, and color management applications; and a range of electromechanical and electronic motion control products. This segment also offers devices that sense, monitor and control operational or manufacturing variables; instruments, controls, and monitoring systems used in electric utilities and industrial facilities; engineered energetic materials components; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Joyce Thomas Patrick JRPresident and CEOOct 21Option Exercise28.5536,1251,031,369205,407Oct 24 06:04 PM
Joyce Thomas Patrick JRPresident and CEOOct 21Sale79.6836,1252,878,296169,282Oct 24 06:04 PM
Joyce Thomas Patrick JRPresident and CEOAug 01Option Exercise28.5536,1251,031,369205,407Aug 02 06:07 PM
Joyce Thomas Patrick JRPresident and CEOAug 01Sale81.4445,8973,737,980169,282Aug 02 06:07 PM
COMAS DANIEL LEVP & CFOJul 27Option Exercise22.2696,4462,147,333259,270Jul 29 07:56 AM
COMAS DANIEL LEVP & CFOJul 27Sale80.8896,4467,800,332189,270Jul 29 07:56 AM
HEFNER LINDA PDirectorJul 11Option Exercise23.8810,578252,60320,197Jul 12 04:54 PM
Lalor Angela SSVP, Human ResourcesMay 12Sale97.778,392820,46148,110May 13 08:41 AM
SCHWIETERS JOHN TDirectorMay 06Option Exercise31.578,000252,56026,958May 09 05:36 PM
LICO JAMES AExecutive Vice PresidentApr 27Option Exercise37.7540,0001,510,000181,517Apr 29 07:27 AM
LICO JAMES AExecutive Vice PresidentApr 27Sale96.9358,9545,714,495122,563Apr 29 07:27 AM
Raskas DanielSVP-Corporate DevelopmentApr 22Option Exercise37.0724,300900,80141,524Apr 26 05:03 PM
DANIEL WILLIAM KEVPApr 22Option Exercise39.8226,1401,040,895164,785Apr 26 05:03 PM
COMAS DANIEL LEVP & CFOApr 22Option Exercise37.7589,2803,370,320230,978Apr 26 05:04 PM
COMAS DANIEL LEVP & CFOApr 22Sale95.7189,2808,545,015141,698Apr 26 05:04 PM
DANIEL WILLIAM KEVPApr 22Sale96.0641,1403,952,086123,645Apr 26 05:03 PM
Joyce Thomas Patrick JRPresident and CEOApr 22Sale95.5014,6301,397,165137,246Apr 26 05:04 PM
King WilliamSenior Vice PresidentApr 22Sale96.316,000577,86017,386Apr 26 05:02 PM
Raskas DanielSVP-Corporate DevelopmentApr 22Sale95.9524,3002,331,58517,224Apr 26 05:03 PM
LICO JAMES AExecutive Vice PresidentFeb 29Option Exercise37.2460,0002,234,155186,878Mar 01 05:56 PM
LICO JAMES AExecutive Vice PresidentFeb 29Sale89.2460,0005,354,348141,517Mar 01 05:56 PM
LOHR WALTER GDirectorFeb 26Option Exercise31.578,000252,560461,505Feb 29 05:48 PM
Raskas DanielSVP-Corporate DevelopmentFeb 26Sale89.004,656414,38417,786Feb 29 05:48 PM
LOHR WALTER GDirectorFeb 26Sale89.068,000712,440453,505Feb 29 05:48 PM
EHRLICH DONALD JDirectorFeb 10Option Exercise31.578,000252,56077,905Feb 11 05:46 PM
EHRLICH DONALD JDirectorFeb 10Sale86.008,000688,00069,905Feb 11 05:46 PM
Joyce Thomas Patrick JRPresident and CEOJan 27Option Exercise37.0725,300937,871141,123Jan 28 05:51 PM
Joyce Thomas Patrick JRPresident and CEOJan 27Sale83.9825,3002,124,654115,823Jan 28 05:51 PM
WY Weyerhaeuser Co. daily Stock Chart
Weyerhaeuser Co.
IndexS&P 500 P/E54.91 EPS (ttm)0.56 Insider Own0.10% Shs Outstand746.35M Perf Week-0.68%
Market Cap22.87B Forward P/E27.21 EPS next Y1.13 Insider Trans-48.70% Shs Float738.57M Perf Month-4.46%
Income390.00M PEG10.98 EPS next Q0.16 Inst Own77.80% Short Float1.67% Perf Quarter-0.81%
Sales6.50B P/S3.52 EPS this Y-36.40% Inst Trans-0.01% Short Ratio3.20 Perf Half Y-2.44%
Book/sh12.26 P/B2.50 EPS next Y43.07% ROA2.60% Target Price34.88 Perf Year20.89%
Cash/sh1.03 P/C29.74 EPS next 5Y5.00% ROE6.10% 52W Range21.17 - 33.28 Perf YTD1.83%
Dividend1.24 P/FCF- EPS past 5Y-25.80% ROI9.10% 52W High-7.93% Beta1.33
Dividend %4.05% Quick Ratio0.90 Sales past 5Y3.50% Gross Margin22.30% 52W Low44.72% ATR0.56
Employees12600 Current Ratio1.00 Sales Q/Q26.10% Oper. Margin13.90% RSI (14)49.43 Volatility1.52% 1.77%
OptionableYes Debt/Eq0.96 EPS Q/Q-8.20% Profit Margin7.90% Rel Volume0.94 Prev Close30.57
ShortableYes LT Debt/Eq0.74 EarningsFeb 03 BMO Payout170.50% Avg Volume3.84M Price30.64
Recom2.00 SMA200.03% SMA50-0.21% SMA2000.18% Volume3,611,000 Change0.23%
Jan-09-17Upgrade Raymond James Outperform → Strong Buy
Dec-15-16Downgrade CLSA Outperform → Underperform
Sep-22-16Initiated Goldman Buy $37
Aug-12-16Downgrade Dundee Buy → Neutral
Aug-08-16Downgrade DA Davidson Buy → Neutral $33
Jun-29-16Upgrade DA Davidson Neutral → Buy
May-09-16Downgrade DA Davidson Buy → Neutral $34 → $33
Feb-17-16Reiterated Argus Buy $43 → $28
Jan-19-16Upgrade Dundee Neutral → Buy
Nov-17-15Reiterated RBC Capital Mkts Outperform $37 → $35
Nov-13-15Upgrade Credit Agricole Underperform → Outperform
Sep-15-15Upgrade BofA/Merrill Neutral → Buy
Jul-16-15Downgrade BofA/Merrill Buy → Neutral
Jun-17-15Initiated Dundee Neutral $34
May-04-15Reiterated UBS Sell $29 → $27
Feb-17-15Reiterated Argus Buy $39 → $43
Nov-03-14Reiterated DA Davidson Buy $37 → $40
Aug-18-14Reiterated Argus Buy $36 → $39
Aug-04-14Upgrade DA Davidson Neutral → Buy $33 → $37
Apr-29-13Reiterated UBS Sell $20 → $24
Jan-09-17 08:25AM  Weyerhaeuser upgraded by Raymond James
Jan-06-17 11:40AM  U.S. makes early finding of injury from some softwood lumber from Canada Reuters
07:32AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : January 6, 2017
07:15AM  Weyerhaeuser's (WY) Long-Term Prospects Dimmed by Risks
Jan-03-17 04:49PM  Weyerhaeuser to release fourth quarter results on Feb. 3 PR Newswire
Dec-19-16 12:30PM  Federal Way mulls development moratorium after Weyerhaeuser campus deal falls through at
Dec-17-16 08:25AM  3 Stocks to Buy With Dividends Yielding More Than 4% at Motley Fool
Dec-16-16 07:34AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : December 16, 2016
Dec-14-16 10:20AM  5 Companies Hit 52-Week Highs
Dec-06-16 05:04PM  WEYERHAEUSER CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
05:57AM  Trump's Policies Are Pushing These 5 Industrials Into Breakout Territory
Dec-04-16 09:34PM  Is Weyerhaeuser Co (WY) A Good Stock To Buy Right Now? at Insider Monkey
Dec-02-16 08:45AM  Weyerhaeuser Divests Cellulose Fibers Business for $2.2B
Dec-01-16 09:36AM  Weyerhaeuser completes sale of Cellulose Fibers pulp mills to International Paper PR Newswire
07:29AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : December 1, 2016
Nov-29-16 10:02AM  Hate Checking Your Portfolio? Try These 3 Stocks at Motley Fool
Nov-24-16 12:12PM  Hilton Worldwide Holdings Inc (HLT): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-22-16 12:29PM  ETFs with exposure to Weyerhaeuser Co. : November 22, 2016
Nov-21-16 07:08AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : November 21, 2016
Nov-14-16 12:26PM  5 Top Construction Stocks for the Housing Rebound at Motley Fool
Nov-09-16 10:16AM  Four Global Natural Resource Plays That Are Attractive From the Long Side of the Charts
Nov-07-16 04:35PM  WEYERHAEUSER CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
Nov-03-16 01:04PM  WEYERHAEUSER CO Financials
Nov-02-16 07:19AM  Weyerhaeuser Boosts Core Business with North Pacific Sale
Nov-01-16 04:30PM  Weyerhaeuser completes sale of printing papers business to an affiliate of One Rock Capital Partners PR Newswire
03:28PM  Paper: The Technology That Refuses To Die at Forbes
12:44PM  ETFs with exposure to Weyerhaeuser Co. : November 1, 2016
Oct-31-16 08:00PM  Weyerhaeuser announces leadership changes PR Newswire
05:55PM  RANKED: Highest-paid lobbying firms in Washington state and who's paying them at
10:02AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
06:30AM  Weyerhaeuser Stock Slips on Q3 Revenue Miss (WY) at Investopedia
Oct-29-16 02:21PM  Highlights From Third Avenues Investor Letters at Insider Monkey
Oct-28-16 01:01PM  Edited Transcript of WY earnings conference call or presentation 28-Oct-16 2:00pm GMT
09:02AM  Weyerhaeuser (WY) Beats Q3 Earnings, Lags on Revenues
07:07AM  Q3 2016 Weyerhaeuser Co Earnings Release - Before Market Open
06:03AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:03AM  Weyerhaeuser tops 3Q profit forecasts
04:01AM  Weyerhaeuser (WY) Beats on Q3 Earnings, Lags on Revenues
03:05AM  Weyerhaeuser reports third quarter results PR Newswire
Oct-27-16 04:00PM  Timber-r-r-r ... Lumber Plays Getting Felled
11:25AM  After second quarter payouts, International Paper posts strong third quarter at
10:31AM  Weyerhaeuser Co. : WY-US: Dividend Analysis : October 28th, 2016 (record date) : By the numbers : October 27, 2016
07:50AM  Construction Stocks' Q3 Earnings to Watch on Oct 28: WY, GVA
Oct-26-16 08:11AM  Weyerhaeuser (WY) to Report Q3 Earnings: What to Expect?
Oct-25-16 08:35PM  Bill Bryant's top donors include Paccar CEO, Weyerhaeuser heir and Martin Selig at
08:21PM  Gov. Jay Inslee's top donors include Mariners, Michael Bloomberg and Amazon execs at
Oct-24-16 03:50PM  Weak industrial earnings, cause for concern?
Oct-20-16 06:42AM  Universal Forest (UFPI) Hikes Semi-Annual Dividend By 7%
Oct-18-16 08:12AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : October 18, 2016
Oct-14-16 05:16PM  Weyerhaeuser Company declares dividend on common shares PR Newswire
Oct-13-16 07:58AM  Weyerhaeuser (WY) to Strategically Review Assets in Uruguay
Oct-12-16 01:23PM  Traders turn bullish on Weyerhaeuser
08:50AM  [$$] Weyerhaeuser Explores Sale of Uruguay Business at The Wall Street Journal
07:07AM  Weyerhaeuser explores sale of Uruguay timber business
06:30AM  Weyerhaeuser to explore strategic alternatives for its Uruguay timberlands and manufacturing business PR Newswire
Oct-11-16 05:25PM  Weyerhaeuser shows off its new 'tree fort' headquarters in Seattle's Pioneer Square (Photos) at
Oct-10-16 09:28AM  Weyerhaeuser's (WY) Growth Prospects Offset by Headwinds
Oct-06-16 10:19AM  Stock Market News for October 06, 2016
07:23AM  These 5 Big Stocks Are Breaking Out in October
06:58AM  Weyerhaeuser (WY) to Divest North Pacific to One Rock
Oct-05-16 10:24AM  [$$] Weyerhaeuser Sells Printing-Papers Business at The Wall Street Journal
08:31AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : October 5, 2016
01:10AM  Weyerhaeuser to sell printing papers business to One Rock Capital Partners PR Newswire
Sep-30-16 04:30PM  Weyerhaeuser to release third quarter results on Oct. 28 PR Newswire
Sep-23-16 08:58AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : September 23, 2016
Sep-22-16 04:13PM  The Hot Stock: Weyerhaeuser Gains 5.7% Because That's the Power of Goldman Sachs at +5.74%
01:57PM  Reaction to Weyerhaeuser (WY) 'Buy' Rating at Goldman
12:35PM  Call of the day: Weyerhaeuser & SeaWorld
12:30PM  Goldman Neutral On Paper/Forest Products: Prefers Boise Cascade, Weyerhauser
08:55AM  Weyerhaeuser (WY) Stock Climbs, Gets 'Buy' Rating at Goldman
07:57AM  Early movers: AZO, RAD, CBS, SEAS, BBBY, YHOO, WCIC, JBL, RHT, LMT & more at CNBC
Sep-21-16 07:19PM  Cramer: Don't sweat it, this stock goes to $200 in the long run at CNBC
Sep-20-16 10:43AM  Strong Housing Starts And Chinese Demand Bode Well For Weyerhaeuser
Sep-01-16 10:13AM  Top Research Reports for 1st September, 2016
10:10AM  Stock Market News for September 01, 2016
06:46AM  Weyerhaeuser (WY) Sells Liquid Packaging Facility to Nippon
Aug-31-16 04:30PM  Weyerhaeuser Completes Sale of Liquid Packaging Board Business to Nippon Paper Industries PR Newswire
Aug-30-16 11:50AM  These Seemingly Boring Investments Can Generate Exciting Returns
Aug-29-16 12:13PM  ETFs with exposure to Weyerhaeuser Co. : August 29, 2016
Aug-26-16 08:07AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : August 26, 2016
Aug-24-16 04:30PM  Weyerhaeuser to present at RBC Global Industrials Conference PR Newswire
Aug-22-16 04:31PM  WEYERHAEUSER CO Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Financial Statements and Exhibits
Aug-19-16 04:30PM  Weyerhaeuser Company declares dividend on common shares PR Newswire
Aug-18-16 06:00PM  Chill out, man: Burien is getting a big cold storage warehouse, too at
Aug-16-16 04:45PM  Weyerhaeuser to hold Investor Meeting on Dec. 13 PR Newswire
Aug-14-16 01:35PM  First Eagle Investment Has A Material Fondness for These 5 Materials Stocks at Insider Monkey
Aug-13-16 05:34PM  Five REITs Billionaires Are Fond Of at Insider Monkey
Aug-11-16 01:19PM  ETFs with exposure to Weyerhaeuser Co. : August 11, 2016
Aug-10-16 03:54PM  International Paper: Takeover Time? at
09:42AM  Post Earnings Coverage as Weyerhaeuser Logs Double Digit Growth on Top and Bottomline
09:15AM  Post Earnings Coverage as Weyerhaeuser Logs Double Digit Growth on Top and Bottomline Accesswire
Aug-09-16 10:37AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
Aug-08-16 10:22AM  Weyerhaeuser (WY) Stock Rating Downgraded at Davidson
10:10AM  Company News for August 08, 2016
07:30AM  Building Trades for Weyerhaeuser
Aug-05-16 02:55PM  Edited Transcript of WY earnings conference call or presentation 5-Aug-16 2:00pm GMT
11:00AM  Here's Why Weyerhaeuser Belongs in Your Portfolio
08:12AM  Weyerhaeuser (WY) Stock Advances on Raised 2H Guidance
08:03AM  Weyerhaeuser (WY) Lags Q2 Earnings, Revises Segments
08:02AM  Early movers: COH, CTSH, WLTW, PCLN, LNKD, ATVI, KHC, RAX & more at CNBC
Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Federal Way, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hagen Russell SSenior Vice President and CFOJan 12Option Exercise25.279,600242,59289,763Jan 13 02:06 PM
Merle Denise MSenior Vice PresidentDec 08Option Exercise23.566,503153,19138,062Dec 12 06:54 PM
Merle Denise MSenior Vice PresidentDec 08Sale33.006,503214,59931,559Dec 12 06:54 PM
Merle Denise MSenior Vice PresidentOct 10Option Exercise18.3711,420209,73746,404Oct 12 06:12 PM
Merle Denise MSenior Vice PresidentOct 10Sale31.1215,049468,32531,355Oct 12 06:12 PM
Slater Catherine ISenior Vice PresidentAug 12Sale31.8111,609369,29470,466Aug 16 03:14 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 10Option Exercise16.8059,6861,002,921110,432Aug 11 07:31 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 10Sale32.5859,6861,944,52850,746Aug 11 07:31 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 09Option Exercise9.534,49242,80055,238Aug 10 08:28 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 09Sale32.504,492145,99050,746Aug 10 08:28 PM
Hunter Rhonda DSr. Vice PresidentJul 27Option Exercise23.563,31878,16261,768Jul 27 09:06 PM
Hunter Rhonda DSr. Vice PresidentJul 27Sale33.003,318109,49458,450Jul 27 09:06 PM
HOLLEY RICK RDirectorJul 26Option Exercise24.11181,0434,364,595735,113Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 26Sale32.64181,0435,909,092554,070Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Option Exercise24.41426,95710,423,885981,027Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Sale32.51426,95713,881,368554,070Jul 27 06:46 PM
Hunter Rhonda DSr. Vice PresidentJun 30Option Exercise20.423,29267,22361,742Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 30Sale30.003,29298,76058,450Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 20Sale29.126,500189,28058,019Jun 22 03:35 PM
Bozeman David PDirectorJun 09Sale30.301,92958,4566,262Jun 13 12:42 PM
Emmert Mark ADirectorJun 07Sale31.259,536298,0009,715Jun 08 07:56 PM
CELG Celgene Corporation daily Stock Chart
Celgene Corporation
IndexS&P 500 P/E44.52 EPS (ttm)2.64 Insider Own0.20% Shs Outstand772.56M Perf Week-1.81%
Market Cap90.76B Forward P/E16.64 EPS next Y7.06 Insider Trans-21.16% Shs Float771.97M Perf Month2.08%
Income2.13B PEG1.97 EPS next Q1.59 Inst Own77.70% Short Float0.99% Perf Quarter16.74%
Sales10.81B P/S8.39 EPS this Y-18.80% Inst Trans-0.25% Short Ratio1.57 Perf Half Y14.22%
Book/sh7.28 P/B16.14 EPS next Y19.28% ROA8.00% Target Price138.79 Perf Year11.23%
Cash/sh8.89 P/C13.21 EPS next 5Y22.57% ROE38.40% 52W Range93.05 - 127.00 Perf YTD1.49%
Dividend- P/FCF26.85 EPS past 5Y15.70% ROI8.90% 52W High-7.50% Beta1.75
Dividend %- Quick Ratio3.40 Sales past 5Y20.60% Gross Margin96.00% 52W Low26.25% ATR2.71
Employees6971 Current Ratio3.60 Sales Q/Q27.80% Oper. Margin28.30% RSI (14)48.16 Volatility2.84% 2.11%
OptionableYes Debt/Eq2.53 EPS Q/Q596.20% Profit Margin19.70% Rel Volume0.72 Prev Close117.08
ShortableYes LT Debt/Eq2.44 EarningsJan 26 BMO Payout0.00% Avg Volume4.90M Price117.48
Recom1.80 SMA20-0.21% SMA500.67% SMA2008.71% Volume3,537,500 Change0.34%
Nov-09-16Downgrade Standpoint Research Buy → Hold
Nov-08-16Initiated Mizuho Buy $130
Jul-15-16Initiated Stifel Buy $138
Apr-29-16Reiterated Sun Trust Rbsn Humphrey Buy $145 → $147
Feb-25-16Initiated Citigroup Buy $130
Jan-20-16Initiated Credit Suisse Outperform
Jan-14-16Initiated Standpoint Research Buy $130
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy $145
Jan-07-16Initiated Sun Trust Rbsn Humphrey Buy
Nov-06-15Reiterated UBS Buy $156 → $145
Oct-01-15Upgrade JP Morgan Neutral → Overweight
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $160
Jul-24-15Reiterated UBS Buy $142 → $156
Jul-24-15Reiterated JMP Securities Mkt Outperform $133 → $147
Jul-24-15Reiterated Cantor Fitzgerald Buy $146 → $163
Jul-21-15Reiterated Piper Jaffray Overweight $144 → $160
Jul-15-15Reiterated RBC Capital Mkts Outperform $135 → $150
Jul-15-15Reiterated Barclays Equal Weight $120 → $130
Feb-25-15Reiterated Argus Buy $130 → $155
Jan-16-17 07:43AM  Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : January 16, 2017
Jan-13-17 04:16PM  Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference
07:45AM  Why investor is selling Celgene calls
Jan-12-17 09:35AM  Biotech Short Sellers Run for Cover
Jan-11-17 01:47PM  Analyst: Government wouldn't want to kill goose that lays...
10:50AM  Celgene 2016 Net $5.94 A Share On $11.2B In Sales at Investopedia
09:13AM  Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
07:17AM  Celgene CEO: We're in a miraculous time for cancer
Jan-10-17 05:53PM  Trump Press Conference, Celgene, GW Pharma Lead Investing Action Plan
04:51PM  Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation
04:21PM  What's Next For Celgene at Motley Fool
02:23PM  Why Agios Pharmaceuticals Sank 34.4% in 2016 at Motley Fool
10:25AM  Celgene Set to Buy Swiss Biotech Anokion for $45M at Investopedia
08:55AM  Celgene Issues Preliminary 2016 Results, Lifts 2017 View
08:35AM  Jefferies Has 5 Top Biotech Stocks to Buy for 2017
08:23AM  Here's a Biotech IPO You'll Want to Watch at Motley Fool
Jan-09-17 05:41PM  So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
03:55PM  The Monday Sights, Sounds and Biotech Buzz from the J.P. Morgan Healthcare Conference
02:24PM  Is Celgene Simply the Best Biotech Stock on the Planet? at Motley Fool
01:28PM  Celgene raises 2017 revenue, profit forecast; maintains 2020 view Reuters
12:55PM  Celgene Sees Much Higher Profits, but Wall Street Still Yawns
12:52PM  [video]Celgene Ups Revenue and Profit Projections for 2017, but Stock Falls at TheStreet
12:36PM  Celgene CEO: Would love to meet with President-elect Trum...
12:02PM  [$$] Celgene Anticipates Slowing Sales Growth for Main Drug Revlimid at The Wall Street Journal
11:11AM  Start the New Year off Right with 3 Best Biotech Stocks at Motley Fool
11:09AM  Celgene raises 2017 revenue, profit forecasts Reuters
10:51AM  CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
10:45AM  Celgene Corporation Announces Preliminary 2016 Unaudited Results and 2017 Financial Guidance Business Wire
Jan-08-17 12:12PM  Top Stocks to Buy in 2017 at Motley Fool
Jan-06-17 06:16PM  Cramer's game plan: Banks will be in hog heaven next week at CNBC
02:10PM  Rally will fade away into second half: Analyst
11:25AM  Why Halozyme Therapeutics, Inc Fell 40.6% in 2016 at Motley Fool
10:55AM  Healthcare Stocks to Buy for 2017: Less Risky, More Risky, and Most Risky at Motley Fool
08:19AM  Halozyme (HALO) Up on Positive Phase II Data on PEGPH20
08:17AM  Bristol-Myers, J&J Ink Immunotherapy Research Collaboration
Jan-05-17 05:13PM  CELGENE CORP /DE/ Files SEC form 8-K, Other Events
02:44PM  Top Biotech Picks: "The Strong Will Survive And Thrive" at
10:30AM  Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare
06:21AM  What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
Jan-04-17 05:19PM  Buy health care despite Obamacare battle?
11:55AM  Did Biogen Just Throw in the Towel to Celgene? at Motley Fool
10:39AM  The investing insanity of trying to find the next Amazon at MarketWatch
07:30AM  Celgene Corporation to Announce Fourth Quarter and Full-Year 2016 Results on January 26, 2017 Business Wire
Jan-03-17 06:13PM  Cramer says Congress could be the culprit to end the stock market rally in 2017 at CNBC
10:56AM  A startup trying to get the human body to fight cancer just filed for an IPO
10:44AM  Is It Worth Following Celgene Corporation (CELG) Into Jounce At IPO? at Insider Monkey
08:15AM  Blog Coverage Cytori Announced Stock Purchase Agreement of Up to $20 Million Accesswire
07:30AM  Celgene Corporation to Present at the 35th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-30-16 04:16PM  Gilead Sciences Valuation Compared to Its Peers
01:35PM  Cambridge immunotherapy firm Jounce plots $75M IPO at
09:37AM  Prima (PBMD) Reports Favorable Initial Melanoma Study Data
Dec-29-16 03:05PM  Orkambi Is Still Strong Revenue Driver for Vertex Pharmaceuticals
09:30AM  The Zacks Analyst Blog Highlights: Celgene, 21st Century Fox, Prudential, Amazon and Exelon Zacks
Dec-28-16 06:04PM  Top Research Reports for December 28, 2016 Zacks
10:55AM  Celgene Winding Up for 2017 Breakout (CELG, IBB) at Investopedia
10:10AM  Biotech Short Interest Sinks
09:30AM  The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, Incyte, Eli Lilly, Regeneron Pharmaceuticals and Ophthotech
07:36AM  Whats Behind Amgens Discounted Valuation?
07:32AM  Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold
Dec-27-16 02:45PM  Time for biotech to boom ... or bust?
08:53AM  Forget Alexion (ALXN), Buy These 3 Biotech Stocks Instead
Dec-23-16 03:07PM  Stocks Trade Quietly Ahead Of Long Weekend; Biotechs Lead
02:34PM  Lockheed On Trump's Naughty List? Celgene Rises, Deutsche Holds Tight
09:06AM  Celgene, Evotec Target Unmet Demand in Neurodegenerative Segment
08:45AM  Celgene's Otezla Gains Positive Recommendation from NICE
07:36AM  Otezla Penetrates the Psoriasis, Psoriatic Arthritis Segments
Dec-22-16 11:20AM  What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
11:07AM  9 Stocks Ray Dalio Continues to Buy
10:38AM  This Drug May Become a Long-Term Growth Driver for Celgene
09:07AM  Abraxane Is Still Witnessing Robust Demand in Solid Tumor Segment
09:04AM  Health Care Sector Impacted Markets on December 21
08:25AM  RBC Likes Large Cap Biotech Leaders for 2017 at 24/7 Wall St.
08:06AM  5 Steps To Buying Biotech Stocks at Motley Fool
07:36AM  Pomalyst Still Dominates the Third-Line Multiple Myeloma Segment
04:19AM  Oral OTEZLA® (Apremilast) Receives Positive Nice Recommendation for Adults with Psoriatic Arthritis Business Wire
Dec-21-16 06:05PM  Revlimid Continues to Be a Key Growth Driver for Celgene in 2016
04:17PM  Celgene Expects Strong Revenue Growth in 2016
10:40AM  Juno Gets Breakthrough Therapy Status for Lymphoma Drug
09:41AM  3 Stocks to Buy If the Dow Hits 20,000 at Motley Fool
08:42AM  Celgene (CELG) Otezla Approved in Japan for Two Indications
Dec-20-16 04:32PM  Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High
02:48PM  Amgen: You're Not the One at
01:28PM  Biotech Stocks: There Go the Generalists at
12:59PM  Reasons To Own Regeneron In 2017; CS Sees 30% Upside at
12:36PM  Celgene Added To CS Focus List; "The Best House In The Biotech Neighborhood" at
11:51AM  3 Incredibly Cheap Biotech Stocks at Motley Fool
09:00AM  Juno Therapeutics and Celgene Corporations Investigational Drug JCAR017 Granted Breakthrough Therapy Designation from FDA and Priority Medicines Eligibility from EMA for Relapsed/Refractory Diffuse Large B-cell Lymphoma Business Wire
08:55AM  Top Analyst Upgrades and Downgrades: Amgen, American Express, American Water Works, Celgene, Square and More at 24/7 Wall St.
07:50AM  Better Buy: Celgene Corporation vs. Johnson & Johnson at Motley Fool
07:30AM  Oral PDE-4 Inhibitor, OTEZLA®, Approved for the Treatment of Plaque Psoriasis and Psoriatic Arthritis in Japan Business Wire
Dec-19-16 03:09PM  3 Small Biotech Stocks That Big Biotechs Like at Motley Fool
09:51AM  Great News: Clinical Trial Success Rates Are Up for the First Time in More Than a Decade at Motley Fool
08:47AM  Agios Stops Development of PKR Activator AG-519, Stock Falls
Dec-16-16 06:29PM  Is Billionaire Julian Robertson Struggling With Large-Cap Stocks? at Insider Monkey
Dec-15-16 05:37PM  3 Biggest Risks for Celgene Corporation at Motley Fool
Dec-14-16 03:54PM  Biotech ETF holds gains
09:30AM  The Zacks Analyst Blog Highlights: Celgene, Regeneron Pharmaceuticals, Ophthotech and Exelixis
Dec-13-16 08:09AM  3 Great Stocks to Beat the Biotech Blues
Dec-12-16 05:02PM  CELGENE CORP /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
02:05PM  3 Biotech Buybacks With the Biggest Bang for the Buck at Motley Fool
Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, ankylosing spondylitis, Behcet's disease, atopic dermatitis, and ulcerative colitis. The company's products also include VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); THALOMID for the patients with multiple myeloma and erythema nodosum leprosum; ISTODAX to treat cutaneous and peripheral T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN products. Its clinical stage products include OTEZLA for the treatment of various immune-inflammatory diseases; sotatercept for the treatment of renal anemia, beta-thalassemia and MDS; luspatercept for beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; PDA-002 for the treat diabetic foot ulcers and peripheral neuropathy; and PNK-007 for hematological malignancies treatment. The company has collaborative agreements with Novartis Pharma AG; Acceleron Pharma; Agios Pharmaceuticals, Inc.; Epizyme Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; Acetylon Pharmaceuticals, Inc.; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; TriNetX, Inc.; Triphase Accelerator Corporation; Nurix Inc.; Abbott; Sage Bionetworks; and PharmAkea Inc. The company was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HUGIN ROBERT Jsee remarksJan 05Option Exercise27.4322,708622,767913,909Jan 09 04:11 PM
Smith Scott AndrewSee RemarksDec 23Option Exercise0.006,400039,875Dec 27 04:17 PM
PEHL MICHAEL F.See remarksDec 02Option Exercise0.001,88001,880Dec 06 04:05 PM
Smith Scott AndrewSee RemarksDec 02Option Exercise0.003,750035,419Dec 06 04:05 PM
FOUSE JACQUALYN Asee remarksDec 02Option Exercise0.005,000084,392Dec 06 04:04 PM
Alles Mark JSee RemarksDec 02Option Exercise0.006,5600166,134Dec 06 04:03 PM
VESSEY RUPERTSee remarksNov 22Sale123.182,500307,9501,150Nov 30 04:15 PM
PEHL MICHAEL F.See remarksNov 10Option Exercise68.3920,4241,396,77022,052Nov 15 04:22 PM
PEHL MICHAEL F.See remarksNov 10Sale121.0422,0522,669,1490Nov 15 04:22 PM
Friedman Michael ADirectorNov 09Option Exercise31.8018,600591,48018,600Nov 10 04:14 PM
Friedman Michael ADirectorNov 09Sale116.1018,6002,159,4600Nov 10 04:14 PM
HUGIN ROBERT Jsee remarksNov 09Sale120.00100,00012,000,000922,201Nov 14 05:47 PM
CELGENE CORP /DE/10% OwnerOct 24Buy14.00800,15011,202,1004,834,980Oct 26 04:15 PM
CASEY MICHAEL DDirectorOct 18Option Exercise100.067,500750,45092,985Oct 19 04:16 PM
Friedman Michael ADirectorOct 03Option Exercise29.8656,1161,675,36456,116Oct 05 04:09 PM
Friedman Michael ADirectorOct 03Sale103.6656,1165,816,9850Oct 05 04:09 PM
BARKER RICHARD WDirectorSep 23Option Exercise36.9220,000738,40031,332Sep 26 04:08 PM
BARKER RICHARD WDirectorSep 23Sale110.8220,0002,216,40011,332Sep 26 04:08 PM
MARIO ERNESTDirectorSep 23Sale109.4215,0001,641,30090,058Sep 26 04:08 PM
KAPLAN GILLADirectorSep 19Option Exercise29.267,500219,45079,642Sep 20 04:42 PM
KAPLAN GILLADirectorSep 15Sale106.449,7101,033,53272,142Sep 16 04:15 PM
LOUGHLIN JAMES JDirectorAug 23Option Exercise26.3627,500724,85050,419Aug 24 04:28 PM
LOUGHLIN JAMES JDirectorAug 23Sale114.1027,5003,137,75022,919Aug 24 04:28 PM
CASEY MICHAEL DDirectorAug 22Sale114.0143,1344,917,70785,485Aug 23 04:29 PM
HUGIN ROBERT Jsee remarksJul 28Sale110.00100,00011,000,0001,022,201Aug 01 05:04 PM
MARIO ERNESTDirectorJul 01Option Exercise0.007330105,058Jul 05 04:32 PM
LOUGHLIN JAMES JDirectorJul 01Option Exercise0.00733022,919Jul 05 04:30 PM
Friedman Michael ADirectorJul 01Option Exercise0.0073300Jul 05 04:27 PM
KAPLAN GILLADirectorJul 01Option Exercise0.00733081,852Jul 05 04:28 PM
COX CARRIE SMITHDirectorJul 01Option Exercise0.00733023,146Jul 05 04:27 PM
BARKER RICHARD WDirectorJul 01Option Exercise0.00733011,551Jul 05 04:25 PM
CASEY MICHAEL DDirectorJul 01Option Exercise0.0073300Jul 05 04:26 PM
HUGIN ROBERT Jsee remarksJun 20Sale100.1675,0007,512,0001,122,201Jun 22 04:42 PM
KAPLAN GILLADirectorJun 17Option Exercise0.00333081,119Jun 17 04:18 PM
CASEY MICHAEL DDirectorJun 17Option Exercise0.0033300Jun 17 04:13 PM
Friedman Michael ADirectorJun 17Option Exercise0.0033300Jun 17 04:14 PM
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
COX CARRIE SMITHDirectorJun 16Option Exercise0.006,200022,413Jun 17 04:14 PM
KAPLAN GILLADirectorJun 15Option Exercise0.006,200080,786Jun 17 04:18 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.002,068021,853Jun 13 05:10 PM
MARIO ERNESTDirectorJun 12Option Exercise0.002,0680103,992Jun 13 05:10 PM
KAPLAN GILLADirectorJun 12Option Exercise0.002,068074,586Jun 13 05:09 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.002,068011,439Jun 13 05:08 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.002,06800Jun 13 05:08 PM
Friedman Michael ADirectorJun 12Option Exercise0.002,06800Jun 13 05:09 PM
Alles Mark JSee RemarksApr 29Option Exercise0.0011,0000164,636May 03 04:30 PM
HUGIN ROBERT Jsee remarksApr 29Option Exercise0.0060,00001,228,311May 03 04:19 PM
Smith Scott AndrewSee RemarksApr 29Option Exercise0.0010,000036,656May 03 09:28 PM
MARIO ERNESTDirectorApr 26Option Exercise31.805,000158,975101,924Apr 28 04:09 PM
KAPLAN GILLADirectorApr 04Sale101.8415,9671,626,07972,518Apr 05 04:15 PM
BONNEY MICHAEL WDirectorMar 03Buy103.012,000206,0282,000Mar 04 04:33 PM
LOUGHLIN JAMES JDirectorFeb 22Sale104.122,100218,65219,785Feb 24 04:56 PM
MARIO ERNESTDirectorFeb 01Option Exercise29.0018,600539,400101,049Feb 02 04:50 PM
Alles Mark JSee RemarksJan 29Option Exercise27.5121,938603,586139,685Feb 02 04:46 PM
CVS CVS Health Corporation daily Stock Chart
CVS Health Corporation
IndexS&P 500 P/E17.49 EPS (ttm)4.69 Insider Own0.23% Shs Outstand1.07B Perf Week-0.27%
Market Cap88.09B Forward P/E13.99 EPS next Y5.86 Insider Trans0.00% Shs Float1.06B Perf Month2.28%
Income5.09B PEG1.64 EPS next Q1.67 Inst Own82.60% Short Float1.29% Perf Quarter-6.38%
Sales172.70B P/S0.51 EPS this Y16.80% Inst Trans0.01% Short Ratio1.63 Perf Half Y-14.77%
Book/sh33.66 P/B2.44 EPS next Y0.91% ROA5.10% Target Price87.95 Perf Year-12.61%
Cash/sh2.11 P/C38.93 EPS next 5Y10.69% ROE13.20% 52W Range69.30 - 105.68 Perf YTD3.89%
Dividend2.00 P/FCF13.98 EPS past 5Y13.30% ROI9.40% 52W High-22.43% Beta0.86
Dividend %2.44% Quick Ratio0.60 Sales past 5Y9.90% Gross Margin16.50% 52W Low18.30% ATR1.44
Employees155000 Current Ratio1.20 Sales Q/Q15.50% Oper. Margin5.10% RSI (14)61.46 Volatility1.46% 1.69%
OptionableYes Debt/Eq0.74 EPS Q/Q29.70% Profit Margin2.70% Rel Volume0.54 Prev Close82.60
ShortableYes LT Debt/Eq0.71 EarningsFeb 09 BMO Payout38.60% Avg Volume8.42M Price81.98
Recom1.90 SMA202.22% SMA504.34% SMA200-9.76% Volume4,581,400 Change-0.75%
Dec-12-16Downgrade Jefferies Buy → Hold
Nov-09-16Reiterated Mizuho Buy $111 → $90
Aug-04-16Reiterated Mizuho Buy $108 → $111
Aug-03-16Reiterated Deutsche Bank Hold $99 → $108
Jun-23-16Reiterated Mizuho Buy $117 → $108
Jun-22-16Reiterated Deutsche Bank Hold $105 → $99
Jun-20-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-04-16Reiterated RBC Capital Mkts Outperform $110 → $115
May-04-16Reiterated Mizuho Buy $104 → $117
Mar-10-16Reiterated Barclays Overweight $110 → $115
Feb-10-16Reiterated Mizuho Buy $113 → $104
Feb-03-16Initiated Atlantic Equities Overweight
Jan-22-16Initiated Robert W. Baird Outperform $108
Dec-18-15Resumed Barclays Overweight $110
Dec-17-15Reiterated Oppenheimer Outperform $115 → $117
Dec-17-15Downgrade Goldman Buy → Neutral
Aug-28-15Reiterated Oppenheimer Outperform $122 → $119
Aug-10-15Reiterated Argus Buy $114 → $118
Aug-05-15Reiterated RBC Capital Mkts Outperform $117 → $132
Jul-22-15Reiterated Deutsche Bank Hold $108 → $117
Jan-16-17 08:41AM  3 Stocks the Market Loves to Hate but That You Should Love at Motley Fool
Jan-15-17 12:01PM  CVS takes on Mylans EpiPen with much cheaper version of an alternative at MarketWatch
Jan-13-17 01:39PM  Examining Volkswagen and Fiat Chrysler's Emissions Cheating Scandals
12:46PM  Hate Checking Your Portfolio? Try These 3 Stocks at Motley Fool
09:30AM  Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlighted as Zacks Bull and Bear of the Day
Jan-12-17 07:43PM  Cheaper Epinephrine: Spend Way Less With This EpiPen Alternative
05:53PM  UPDATE 1-CVS slashes price of Impax's EpiPen rival Reuters
05:52PM  CVS slashes price of Impax's emergency allergy shot Reuters
05:21PM  Mylan Crushed by Trump, Cigna and CVS -- All In Two Days
05:04PM  Stock Market Roundup, Jan. 12: AMZN Jobs, FCAU Cheating, AKS & X Tank
01:05PM  CVS Debuts Cheap EpiPen Alternative
11:55AM  CVS Is the Latest to Rock Mylan's EpiPen Empire
10:36AM  CVS generic competitor to EpiPen, sold at a 6th the price
10:36AM  How Does Walgreenss Valuations Compare to Its Peers?
10:20AM  CVS Health Corp (CVS) Goes After Mylan NV (MYL) With Cheaper Generic EpiPen
09:43AM  Cigna Defends Abandoning EpiPen Coverage
09:06AM  After Walgreenss 1Q17 Results, Wall Street Remains Positive
08:50AM  CORRECTED: CVS to offer low-cost version of alternative to EpiPen priced at $109.99 for a two-pack at MarketWatch
08:00AM  CVS Health Offers Patients Lowest Cash Price in the Market for Generic Epinephrine Auto-injector to Treat Allergic Reactions PR Newswire
07:36AM  Evaluating Walgreens from a Dividend Investors Perspective
Jan-11-17 10:36AM  Why Walgreens Stock Has a Better Upside Potential Than Peers
09:07AM  Walgreens Expects a Stronger 2017, Thanks to New Deals
Jan-10-17 02:05PM  Walgreens Reported Top-Line Fall for First Time in 4 Years
12:20PM  Is 2017 the Year of the Retail Famine?
11:35AM  U.S. top court grapples with credit card surcharge law dispute Reuters
Jan-09-17 05:43PM  Is 2017 the Year of the Retail Glut?
04:17PM  Baidu,, Texas Instruments Upgraded; Juniper Rating Cut
10:22AM  Why CVS Could Be Lethal for Your Otherwise Healthy Portfolio
10:00AM  Flu Shots Available at CVS Pharmacy Locations in Washington PR Newswire
07:10AM  What Happens If Walgreens' Acquisition of Rite Aid Falls Through? at Motley Fool
Jan-08-17 07:25AM  Will CVS Health Corporation Raise Its Dividend in 2017? at Motley Fool
Jan-06-17 12:55PM  [$$] CVS Has an Edge on Walgreens at
10:55AM  Healthcare Stocks to Buy for 2017: Less Risky, More Risky, and Most Risky at Motley Fool
Jan-05-17 03:21PM  Why CVS Health Stock Dropped 18.2% in 2016 at Motley Fool
10:56AM  CVS Health Corp. Value Analysis (NYSE:CVS) : January 5, 2017
Jan-04-17 08:34AM  CVS Health Corp. breached its 50 day moving average in a Bullish Manner : CVS-US : January 4, 2017
Jan-02-17 07:28AM  Drugstore Chain CVS Poised for a Rebound
Jan-01-17 05:48PM  Bargain Hunting: The 10 Worst-Performing Dividend Achievers of 2016
Dec-30-16 12:00PM  CVS Health To Present At The 35th Annual J.P. Morgan Healthcare Conference PR Newswire
10:15AM  5 UBS Quality Growth at a Reasonable Price Stocks to Own for 2017 at 24/7 Wall St.
Dec-29-16 01:15PM  [$$] CVS Stock Set to Outperform at
08:00AM  E.l.f. Beauty CEO Amin On Social Cosmetics And The Ageless Beauty Boom
Dec-28-16 11:22AM  3 Reasons CVS Health is Still a Buy at
Dec-27-16 01:08PM  3 Best Stocks for Retirees at Motley Fool
11:36AM  Sanofi sues Novo Nordisk over diabetes drugs in the U.S.
Dec-22-16 02:20PM  December Magic Diligence Stock of the Month: CVS Health
11:34AM  Rite Aid Notes 'Difficult' Environment As Walgreens Deal Drags
10:37AM  Walgreens Boots Alliances SWOT Analysis ahead of 1Q17 Results
09:06AM  Comparing Walgreens Boots Alliances Valuations to Its Peers
07:36AM  How Will the US Drugstore Industry Look after the Freds-Rite Aid Deal?
07:36AM  Walgreens Stock Has a Potential Upside of 8.0% over the Next Year
Dec-21-16 04:23PM  Will 2017 Be CVS Health Corporation's Worst Year Yet? at Motley Fool
04:16PM  David Dreman Gains, Increases Multiple Positions in 3rd Quarter
02:05PM  Walgreens Moves One Step Closer to the Rite Aid Deal Closure
12:35PM  Rite Aid Deal to Make Freds the Third-Largest US Drugstore Chain
10:37AM  Knowing More about Walgreens Boots Alliance, Dividend Aristocrat
08:57AM  Bob Doll's top 5 stocks for 2017
08:24AM  New Strong Sell Stocks for December 21st
07:36AM  Walgreens Boots Alliances Earnings: A Look into Fiscal 2017
Dec-20-16 06:05PM  Walgreens Boots Alliances Top Line: Will It Shape Up?
04:35PM  A Sneak Peek at Walgreens Fiscal 2016 Top-Line Performance
02:57PM  1Q17 Earnings Preview: What to Expect from Walgreens
08:37AM  Better Buy: CVS Health Corp. vs. Wal-Mart Stores, Inc. at Motley Fool
08:24AM  CVS Health (CVS) Down on Prevailing Risks, Tepid Guidance
Dec-19-16 08:05AM  Find Last Minute Holiday Gifts and Essentials at CVS Pharmacy PR Newswire
Dec-18-16 12:12PM  [$$] US charges 200 times UK price for common worm pill at Financial Times
12:00PM  Trifecta Stocks Portfolio: Rate Hike, A Fed Story
Dec-16-16 04:52PM  Mylan launching generic EpiPen
10:21AM  Where to Invest Money in 2017: 3 Great Ideas at Motley Fool
08:35AM  5 Merrill Lynch US 1 Stocks Could Be Poised for a Big 2017 at 24/7 Wall St.
08:35AM  CVS Health Revises View for 2016 & 2017, Declares Dividend
08:25AM  CVS Health Introduces Transform Diabetes Care Program
08:15AM  Blog Coverage CVS Health Reaffirms Earnings Outlook; Raises Dividend by 18% Accesswire
07:22AM  Heres where contrarian investors plan to make their money in 2017 at MarketWatch
Dec-15-16 06:55PM  Atlanta investor sells Irving office tower, exits Dallas market, as part of a $109.5M deal at
11:29AM  CVS Posts 2017 Guidance in Line With Estimates; Share Prices Fall
08:01AM  CVS to raise its dividend by 18% next year, affirms profit outlook at MarketWatch
07:37AM  CVS HEALTH CORP Files SEC form 8-K, Regulation FD Disclosure
07:30AM  CVS Health Holds 2016 Annual Analyst Day Outlining Strategies to Drive Growth, Expressing Confidence in Long-Term Targets; Announces 18% Dividend Increase for 2017 PR Newswire
Dec-14-16 11:00AM  CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Nevada PR Newswire
10:49AM  Why Express Scripts Is Getting Crushed? at
09:35AM  CVS Health Corporation's Biggest Mistake in 2016 at Motley Fool
Dec-13-16 05:14PM  More than 30 retail clinics popped up around Puget Sound region this year at
02:00PM  Nurse Practitioners Win Direct Access To VA Patients at Forbes
09:53AM  Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar
09:14AM  These 5 Stocks Are Decidedly Not Benefiting From the Trump Rally
08:30AM  CVS Health Introduces New "Transform Diabetes Care" Program to Improve Health Outcomes and Lower Overall Health Care Costs PR Newswire
07:00AM  Top 10 Holdings of Our Ultimate Stock-Pickers' Index at Morningstar
Dec-12-16 10:14AM  Fred's Pharmacies' Sale May Be Back on the Table
09:14AM  Bulls turning to consumer staples
09:10AM  CVS Health's Outlook For Next Year Hampered By 2 Factors
08:55AM  Top Analyst Upgrades and Downgrades: AMD, CVS Health, ConocoPhillips, EOG Resources, Seattle Genetics, WebMD and More at 24/7 Wall St.
08:35AM  Rx for CVS Health: Cover Shorts, but Be Patient Before Going Long
08:19AM  Early movers: NWL, T, CVS, FOXA, BA, FINL, & more at CNBC
06:58AM  CVS Health downgraded by Jefferies
06:24AM  Stocks to Watch: December 12, 2016
Dec-09-16 08:08PM  Jim Cramer's 'Mad Money' Recap: Here's What You Should Watch Next Week
05:14PM  U.S. Share Buyback Authorizations Sizzle in November at The Wall Street Journal
05:02PM  Walgreens May Be Close To Store Divestitures In Rite Aid Deal at Forbes
10:39AM  Analysts Skeptical of Andrew Left's Express Scripts Criticism
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MERLO LARRY JPresident and CEOMay 05Option Exercise36.2338,2471,385,689280,381May 06 04:26 PM
GOLD STEPHEN JEVP & CIOMay 05Option Exercise47.299,798463,34731,358May 06 04:29 PM
GOLD STEPHEN JEVP & CIOMay 05Sale105.009,7981,028,79021,560May 06 04:29 PM
Brennan Troyen AEVP and Chief Medical OfficerMay 05Sale105.007,517789,28569,601May 06 04:28 PM
MERLO LARRY JPresident and CEOMay 05Sale105.0038,2474,015,935242,134May 06 04:26 PM
GOLD STEPHEN JEVP & CIOApr 01Option Exercise47.2921,9221,036,69142,048Apr 05 06:39 PM
Sussman AndrewEVP & Pres, CVS MinuteClinicApr 01Sale105.002,844298,62011,041Apr 05 07:21 PM
GOLD STEPHEN JEVP & CIOApr 01Sale105.0021,9222,301,81020,126Apr 05 06:39 PM
Brennan Troyen AEVP, Chief Medical OfficerMar 09Sale100.006,755675,50069,601Mar 11 04:08 PM
Roberts Jonathan CEVP & President, CVS/caremarkFeb 11Sale92.8623,3552,168,74528,644Feb 11 05:17 PM
MERLO LARRY JPresident and CEOFeb 01Option Exercise28.1046,3931,303,643208,021Feb 02 04:17 PM
MERLO LARRY JPresident and CEOFeb 01Sale96.1446,3934,460,010161,628Feb 02 04:17 PM
XLV Health Care Select Sector SPDR ETF daily Stock Chart
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.04%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.14%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter1.63%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio2.65 Perf Half Y-3.47%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year6.24%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range61.69 - 75.38 Perf YTD2.87%
Dividend1.13 P/FCF- EPS past 5Y- ROI- 52W High-5.91% Beta-
Dividend %1.59% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low14.95% ATR0.70
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)60.01 Volatility1.16% 0.90%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.48 Prev Close70.85
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume10.77M Price70.92
Recom- SMA201.53% SMA502.59% SMA2000.43% Volume5,239,300 Change0.10%
Jan-13-17 12:19PM  Farr: Have to look at stocks on a stock-by-stock basis
12:12PM  Farr: Washington's messy, and there's room to disappoint ...
10:38AM  Behind Johnson & Johnsons Recent Stock Performance
Jan-12-17 04:31PM  Joe Tigay's Health Care SPDR ETF Options Trade
12:26PM  Eli Lilly's stock rallies after appeals court upholds favorable patent ruling at MarketWatch
07:08AM  Trump Tries Recent Enthusiasm For Healthcare ETFs
Jan-11-17 02:05PM  What Does the December Jobs Report Mean for the Economy?
01:58PM  Stocks under pressure as Trump targets drugmakers
01:41PM  Healthcare Slammed As Trump Vows To Fight Drug Prices at Investopedia
01:39PM  Trump says drugmakers are 'getting away with murder,' and biotech stocks plunge at CNBC
11:30AM  Biotech ETFs fall as Trump says more bidding needed on drugs at MarketWatch
08:47AM  Traders see floor in health-care fund
Jan-10-17 10:06AM  Illumina's stock soars toward best gain in 5 years after upbeat sales outlook, product upgrade at MarketWatch
Jan-09-17 09:28AM  Technology Rules as Only S&P Sector Hitting a New High
Jan-06-17 02:05PM  Zimmer Biomet Holdings: Hows Its Recent Stock Performance?
12:27PM  The 'Super Bowl' for health care investors
10:56AM  Analysts Recommendations for Zimmer Biomet Holdings
Jan-05-17 07:35AM  How Do Wall Street Analysts View Becton Dickinson?
Jan-04-17 05:19PM  Buy health care despite Obamacare battle?
04:05PM  Which Sector Returned the Most in 2016?
10:35AM  A Look at Becton Dickinsons Recent Stock Performance
09:05AM  Inside Becton Dickinsons Financial Guidance for 2017
08:34AM  Stock pickers await end of rising tide market at MarketWatch
Jan-03-17 01:05PM  What Investors Should Know about the Consumer Staples Sector
11:23AM  Is the 2017 Outlook for Healthcare Optimistic?
09:06AM  The Impact of Gilead Sciences Other Products
06:54AM  Best Sector ETFs For January: Trying To Get Healthy
Dec-29-16 01:00PM  Historical Sector ETF Performance for January (XLV, XLK) at Investopedia
10:36AM  When Will the Biosimilar for Enbrel Be Available?
Dec-28-16 01:36PM  Keytruda Is Still a Strong Growth Driver for Merck
Dec-27-16 05:16AM  2017 Playbook: Health care
Dec-23-16 04:35PM  MDTs Fitbit Collaboration Set to Accelerate Diabetes Management
Dec-22-16 11:49AM  Meet This Year's Best Healthcare ETF
09:07AM  Abraxane Is Still Witnessing Robust Demand in Solid Tumor Segment
Dec-21-16 12:12PM  Chase: Health care stocks are cheap
09:07AM  Baraclude Faces Declining Revenues in 2016
Dec-20-16 07:35AM  Inside Edwards Lifesciences Financial Guidance for 2017
Dec-19-16 02:04PM  Stock Pickers' Delight: S&P 500 Correlations Plunge at The Wall Street Journal
Dec-16-16 12:00PM  Dow 20K watch: Here's what investors should monitor
11:48AM  Good Time to Sell Russell 2000 Puts
11:48AM  Bond Sentiment Weak, but Small-Cap Index Rallies
07:35AM  Dupixent: Leading Therapy for Atopic Dermatitis in the Future?
05:55AM  Health care stocks to lose 50% and 9 other outrageous analyst predictions at MarketWatch
Dec-15-16 01:54PM  The Word on the Street: What Analysts Are Recommending for Edwards Lifesciences Now
10:05AM  What Were Pfizers Major Achievements in 2016?
06:58AM  Eli Lilly's stock jumps after profit and sales outlook exceed expectations at MarketWatch
Dec-14-16 10:27AM  Markets Set Chances of Fed Rate Hike at 90%
09:28AM  Heres when post-election stock surges typically fizzle out at MarketWatch
Dec-13-16 06:00PM  Final Trade: KO, XLK and more
05:10PM  BlackRock: Here's what to buy
05:00PM  Dow surges towards 20K: What to buy?
Dec-12-16 12:03PM  Pfizer raises dividend 7%; stock surges at MarketWatch
Dec-09-16 07:11PM  A Record Week For Stock ETFs, But Is The Market Rally Warranted?
04:04PM  Dow, in Another Record Close, Ends With Weekly Gains for Fifth Consecutive Week
03:14PM  Stocks on Track for Fresh Records as Health Care Sector Climbs
02:46PM  Pfizer Up Along with Other Healthcare Stocks at Investopedia
02:35PM  Pfizers Eighth Consecutive Quarter of Revenue Growth
01:05PM  Understanding Pfizers 3Q16 Performance
10:35AM  Why Bernstein Thinks Investors Should Be in Cyclical Sector
07:12AM  Eli Lilly to pay AstraZeneca $30 million as part of a collaboration on an Alzheimer's treatment at MarketWatch
Dec-08-16 04:49PM  Beardstown Ladies president: If we do hit a correction, i...
01:51PM  The famous Beardstown Ladies on the markets
07:20AM  United Health Services 'dispute and deny' BuzzFeed report at MarketWatch
Dec-07-16 06:36PM  S&P 500 ETFs Set New Highs, But Biotechs Give Back Most Of Trump Rally
05:07PM  Are there buying opportunities in health care?
12:40PM  Trumps Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares at 24/7 Wall St.
10:43AM  David Einhorns Investment Guidance at the Robin Hood Conference
08:06AM  Will the November Jobs Report Delay the Feds Rate Hike Urgency?
Dec-06-16 08:39AM  Your first trade for Tuesday, December 6th at CNBC
Dec-05-16 12:25PM  Can Donald Trump Make Valeant Stock Great Again? (VRX, XLV) at Investopedia
Dec-02-16 02:04PM  The Fuel for Todays Reflationary Fire: What You Need to Know
10:58AM  Which US Sectors Look Appealing in the Reflationary Environment?
08:04AM  Keytruda Is Mercks Immuno-Oncology Business
07:32AM  The controversial medical association that counts Trump nominee Tom Price among its members at MarketWatch
Nov-30-16 06:30PM  What Do Analysts Recommend for Boston Scientific?
10:48AM  What Are Analysts Recommendations for Thermo Fisher Scientific?
10:04AM  Scrutinizing the HCV Market Based on Genotypes
09:38AM  Markets Set Chance of Fed Rate Hike at 90%
Nov-29-16 01:26PM  Analyzing Allergans Growth Pharma Plans
11:04AM  What Really Disrupted Medtronics Diabetes Segment Sales in Fiscal 2Q17?
08:06AM  Acthars Higher Exposure to Government-Oriented Franchise
Nov-28-16 10:05AM  Humira Has Been a Key Growth Driver for AbbVie in 2016
10:04AM  How Did Bristol-Myers Squibbs Virology Segment Perform in 3Q16?
Nov-25-16 07:09AM  What Eli Lillys hard fall in Alzheimers treatment race means for its competitors at MarketWatch
Nov-24-16 11:04AM  This Is Eli Lillys Animal Health Segment
Nov-23-16 10:36AM  Health Care ETFs Fall As Eli Lilly, Juno Add To Troubled Sector's Woes
10:04AM  BMYs Orencia Has Been Approved to Treat Methotrexate-Naive Patients
08:39AM  Why Sector ETFs May Be Better Than Individual Stocks
Nov-22-16 12:33PM  This underperforming sector means good things for the rest of the market at MarketWatch
10:08AM  How Stocks and Bonds Reacted to Trumps Victory
08:04AM  Bristols Opdivo Has One Eye on Advanced Bladder Cancer
07:18AM  Medtronic's stock tumbles after revenue miss, downbeat profit outlook at MarketWatch
Nov-21-16 12:00PM  A Thanksgiving Holiday Health Care Play
10:50AM  The Positive Performance of the Healthcare Sector
09:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Ascena Retail, Financial Sector, Industrials and Health care
Nov-18-16 07:04PM  How Will the US Elections Results Impact Strykers Business?
05:10PM  Trump Rotation Stocks to Buy Right Now
Nov-16-16 04:04PM  How Has Medtronics Stock Performed Recently?
Nov-15-16 05:07PM  Investing in a Trump world
Nov-14-16 02:58PM  These hot trades will only get hotter: Traders at CNBC
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG Conagra Brands, Inc. daily Stock Chart
Conagra Brands, Inc.
IndexS&P 500 P/E37.94 EPS (ttm)1.02 Insider Own0.10% Shs Outstand435.21M Perf Week-0.59%
Market Cap16.76B Forward P/E20.57 EPS next Y1.87 Insider Trans-7.69% Shs Float431.00M Perf Month0.26%
Income448.00M PEG2.94 EPS next Q0.44 Inst Own77.90% Short Float1.28% Perf Quarter6.02%
Sales10.51B P/S1.60 EPS this Y-36.90% Inst Trans0.34% Short Ratio1.51 Perf Half Y4.24%
Book/sh10.16 P/B3.79 EPS next Y10.70% ROA4.90% Target Price41.33 Perf Year26.44%
Cash/sh3.31 P/C11.62 EPS next 5Y12.90% ROE16.10% 52W Range28.89 - 39.97 Perf YTD-2.63%
Dividend0.80 P/FCF26.48 EPS past 5Y-10.30% ROI7.30% 52W High-3.65% Beta0.30
Dividend %2.08% Quick Ratio1.30 Sales past 5Y-1.20% Gross Margin28.40% 52W Low33.30% ATR0.58
Employees20900 Current Ratio1.90 Sales Q/Q-11.50% Oper. Margin9.20% RSI (14)52.05 Volatility1.17% 1.58%
OptionableYes Debt/Eq0.78 EPS Q/Q45.40% Profit Margin6.00% Rel Volume0.61 Prev Close38.51
ShortableYes LT Debt/Eq0.72 EarningsDec 22 BMO Payout69.90% Avg Volume3.66M Price38.51
Recom2.20 SMA20-0.92% SMA502.01% SMA2006.52% Volume2,237,000 Change0.00%
Jan-11-17Upgrade Citigroup Neutral → Buy
Dec-23-16Reiterated Credit Suisse Neutral $35 → $40
Nov-14-16Initiated UBS Neutral $36
Nov-09-16Resumed JP Morgan Overweight $55
Oct-19-16Reiterated Stifel Hold $46 → $52
Oct-14-16Upgrade RBC Capital Mkts Sector Perform → Outperform $50 → $54
Jul-01-16Reiterated RBC Capital Mkts Sector Perform $48 → $50
Apr-08-16Reiterated Jefferies Buy $50 → $52
Apr-04-16Reiterated RBC Capital Mkts Sector Perform $46 → $48
Feb-25-16Resumed Goldman Neutral $48
Feb-12-16Upgrade BofA/Merrill Neutral → Buy
Dec-16-15Initiated Jefferies Buy
Sep-25-15Reiterated Deutsche Bank Hold $38 → $43
Jul-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $37 → $50
Jul-01-15Upgrade BofA/Merrill Underperform → Neutral
Jun-22-15Upgrade JP Morgan Neutral → Overweight
Jun-19-15Reiterated Deutsche Bank Hold $36 → $38
Jun-19-15Reiterated Bernstein Mkt Perform $37 → $44
Sep-19-14Reiterated RBC Capital Mkts Sector Perform $31 → $35
Feb-12-14Reiterated Deutsche Bank Hold $35 → $31
Jan-16-17 10:37AM  Citigroup Upgrades Conagra Brands to a Buy
09:07AM  Raymond James Upgrades Visteon Corporation to Outperform
07:37AM  Who Were the Outliers in the Consumer Space on January 12?
Jan-11-17 09:48AM  Top Ranked Income Stocks to Buy for January 11th
09:30AM  The Zacks Analyst Blog Highlights: JPMorgan, Texas Instruments, Starbucks, ConAgra and NVIDIA
08:43AM  Conagra's (CAG) Growth Initiatives Look Good: Time to Buy?
08:33AM  Brown-Forman's Growth Efforts on Track Amid Currency Woes
06:44AM  ConAgra upgraded by Citigroup
Jan-10-17 01:45PM  Top Research Reports for Starbucks, JPMorgan & Texas Instruments
09:28AM  [$$] Lamb Weston Tops Views in First Quarterly Report at The Wall Street Journal
Jan-09-17 09:01AM  Reddi-wip Introduces New Recipe Business Wire
Jan-07-17 01:04PM  CONAGRA BRANDS INC. Financials
Jan-05-17 09:07AM  Whats the Latest News on Hormel Foods?
Jan-04-17 09:12AM  CONAGRA BRANDS INC. Files SEC form 10-Q, Quarterly Report
08:15AM  Post Earnings Coverage as ConAgra Adjusted EPS Soared 25.6% Accesswire
08:00AM  Microwave Popcorn a Delicious Whole Grain Option for Those Seeking Sensible Snacks PR Newswire
Jan-03-17 03:15PM  Conagra or Ingredion: Which Stock Is More Appealing?
Dec-28-16 05:35PM  Hormel Foods International Names Gadsden Asia-Pacific President
07:00AM  Consumer Defensive: Cooking Up a Bit More Value at Morningstar
Dec-27-16 12:29AM  [$$] Conagra Stock Valuation May Be Full at
Dec-23-16 03:05PM  Understanding Cal-Maine Foods Performance in Fiscal 2Q17
01:35PM  How Did Conagra Brands Perform in 2Q17?
12:00PM  Conagra Brands' Latest Earnings Results Bode Well for Its Shares
11:40AM  The Outliers in the Consumer Space on December 22
08:51AM  ConAgra (CAG) Beats Q2 Earnings, Reaffirms FY17 Guidance
Dec-22-16 06:05PM  Edited Transcript of CAG earnings conference call or presentation 22-Dec-16 2:30pm GMT
04:42PM  Red Hat and Bed Bath & Beyond skid; Hershey edges higher
04:40PM  Where's the Reddi-wip? ConAgra lowers product profile during shortage
03:32PM  Stocks slide again as retailers and tech companies slip
02:26PM  Craving Packaged Food Stocks For 2017? RBC Serves Up 4 Buy-Rated Names
01:06PM  ETFs with exposure to Conagra Brands, Inc. : December 22, 2016
11:36AM  Conagra: Sizzling! at
11:28AM  ConAgra's profit beat sends shares to record high
09:31AM  CORRECTING and REPLACING Conagra Brands Announces Details of Fiscal 2017 Second Quarter Earnings Release and Conference Call Business Wire
09:15AM  Conagra Sales Light, Says on Track With Focus Change
08:58AM  [$$] ConAgra Revenue Falls As it Cuts Discounting at The Wall Street Journal
08:54AM  CONAGRA BRANDS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:07AM  ConAgra beats 2Q profit forecasts
07:54AM  ConAgra's profit beats on less discounting
07:53AM  Early movers: CAG, RAD, NKE, HSY, MU, APC & more at CNBC
07:35AM  ConAgra posts lower-than-expected quarterly sales
07:27AM  Conagra Brands Reports Continued Margin Expansion and EPS Growth in Second Quarter Business Wire
07:07AM  Q2 2017 ConAgra Foods Inc Earnings Release - 09:30 am ET
06:15AM  Stocks to Watch: December 22, 2016
Dec-21-16 05:25AM  When Billionaire Activist Barry Rosenstein Buys These Stocks, You Sell Them at Insider Monkey
Dec-20-16 05:07PM  There's a nationwide shortage of this holiday treat
08:49AM  Breakout time for ConAgra?
08:22AM  Conagra (CAG) Looks Bearish: Should You Sell the Stock?
Dec-19-16 06:01PM  Whippocalypse? U.S. ready-made whipped cream in short supply
09:06AM  J.P. Morgan Rated Pinnacle Foods as Overweight
07:37AM  McCormick & Company Acquired Enrico Giotti SpA for $127 Million
12:07AM  [$$] Processed Food Brands Look for Fresh Makeover at The Wall Street Journal
Dec-17-16 12:08PM  [$$] Processed Food Brands Look for Makeover at The Wall Street Journal
12:08PM  Processed Food Brands Look for Fresh Makeover
Dec-15-16 01:45PM  Conagra Brands Announces Details of Fiscal 2017 Second Quarter Earnings Release and Conference Call Business Wire
09:05AM  Why Did the US Department of Justice Fine ConAgra Brands?
Dec-14-16 04:41PM  Avery Dennison Announces Acquisition of Hanita Coatings
10:32AM  Tainted peanut butter leads to $11.2M penalty a decade later
10:01AM  ConAgra hit with $11.2M fine
09:31AM  TreeHouse Foods Continues to Face Headwinds: Time to Sell?
01:21AM  PRESS DIGEST- New York Times business news - Dec 14 Reuters
Dec-13-16 08:20PM  ConAgra gets largest fine ever in food safety case for poisoned Georgia peanut butter at
05:37PM  [$$] ConAgra Unit Pleads Guilty in Salmonella Outbreak Case at The Wall Street Journal
05:21PM  ConAgra to pay $11.2M to settle tainted peanut butter case
04:17PM  CONAGRA BRANDS INC. Files SEC form 8-K, Change in Directors or Principal Officers
03:46PM  ConAgra unit to pay $8 mln fine for 2006-07 salmonella poisoning -U.S. Justice Dept Reuters
03:12PM  The Latest: ConAgra pleads guilty in salmonella case
02:14PM  Misdemeanor plea on behalf of ConAgra ends decade-long criminal probe over salmonella in Peter Pan peanut butter
Dec-12-16 06:05PM  Conagra Brands Declares a Dividend and a New Board Appointment
08:26AM  TreeHouse Foods (THS) Recalls Products on Salmonella Risk
Dec-10-16 02:26PM  How Synchrony Financial (SYF) Stacks Up Against Its Peers at Insider Monkey
10:49AM  ConAgra to finalize plea deal in tainted peanut butter case
Dec-09-16 07:00AM  ConAgra Splits Its Menu, but We're Not Hungry at Morningstar
Dec-08-16 04:10PM  Conagra Brands Announces Appointment of Thomas W. Dickson to Its Board of Directors Business Wire
Dec-07-16 06:16AM  Is Moodys Corporation (MCO) A Good Stock To Buy? at Insider Monkey
Dec-06-16 09:36AM  KeyBanc Capital Markets Rated Hormel Foods as Sector Weight
12:08AM  [$$] Big Food Battles Meal-Kit Startups for Dinner-in-a-Box at The Wall Street Journal
Dec-05-16 01:56PM  Conagra Brands, Inc. Value Analysis (NYSE:CAG) : December 5, 2016
08:01AM  [$$] Big Food Tests Consumer Appetite for Meal Kits at The Wall Street Journal
06:20AM  Office Envy: In ConAgras Merch Mart HQ, heritage meets the future at
Dec-04-16 02:02PM  Billionaire Dan Loeb Buys Back Into Apple, Adds Alibaba, Visa, More at Insider Monkey
Dec-02-16 07:18AM  Conagra Brands, Inc. breached its 50 day moving average in a Bearish Manner : CAG-US : December 2, 2016
Dec-01-16 09:04AM  Conagra Becomes Very Bullish Above $38
Nov-28-16 08:00AM  Iconic Comfort Food Brand Announces The Dining Room by Marie Callender's® PR Newswire
Nov-27-16 12:19PM  5 Trade Ideas for Monday: Conagra, CBOE, Estee Lauder, Interactive Brokers and 3M
Nov-24-16 03:53PM  Shoud You Add Conagra Brands, Inc. (CAG) to Your Portfolio? at Insider Monkey
Nov-22-16 03:04PM  Hormel Foods Declares Dividend of $0.17 Per Share
11:33AM  Should You Get Rid of Conagra Brands (CAG) Now?
Nov-21-16 11:04AM  How Did J.M. Smucker Perform in Fiscal 2Q17?
Nov-17-16 07:03AM  Conagra Brands, Inc. breached its 50 day moving average in a Bullish Manner : CAG-US : November 17, 2016
Nov-16-16 11:52AM  [$$] Trump Win Makes a Dent in Packaged Foods at
10:05AM  UBS Rated ConAgra Brands as Neutral
08:05AM  Spectrum Brands Holdings Declares Dividend of $0.38 per Share
Nov-15-16 05:18PM  CONAGRA BRANDS INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in Directors or Pr
12:44PM  Conagra Brands Celebrates America Recycles Day with Zero Waste Champion Awards Business Wire
10:04AM  ConAgra Brands Announces Board of Directors Addition
07:38AM  New Strong Sell Stocks for November 15th
Nov-14-16 05:53PM  Which Stocks Were the Outliers in the Consumer Space November 11?
03:59PM  Should ConAgra (CAG) Stock Be Part of Your Portfolio Now?
08:05AM  ConAgra Foods Separated Its Lamb Weston Business
Conagra Brands, Inc., together with its subsidiaries, operates as a food company in North America. It operates through five segments: Grocery & Snacks, Refrigerated & Frozen, International, Foodservice, and Commercial. The Grocery & Snacks segment primarily provides branded, shelf-stable food products in various retail channels in the United States. The Refrigerated & Frozen segment offers branded, temperature controlled food products in various retail channels in the United States. The International segment primarily provides branded food products, in various temperature states, in retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, such as meals, entrees, prepared potatoes, sauces, and various custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The Commercial segment offers commercially branded and private label food and ingredients primarily to commercial, restaurant, foodservice, food manufacturing, and industrial customers. The company markets its products primarily under the Healthy Choice, Hunt's, Slim Jim, Reddi-wip, Alexia, Blake's, Frontera, Bertolli, P.F. Chang's, and Marie Callender's brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GREGOR JOIE ADirectorJan 05Sale39.013,300128,73750,820Jan 09 05:17 PM
Biegger DavidEVP,Chief Supply Chain OfficerNov 17Option Exercise0.006,52806,528Nov 21 05:46 PM
Serrao DarrenEVP, Chief Growth OfficerSep 01Option Exercise0.003,23503,235Sep 06 06:04 PM
Wise Robert GSVP, Corporate ControllerJul 15Option Exercise36.8915,708579,46834,326Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 15Sale47.9015,708752,36618,618Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 14Option Exercise30.8917,245532,69835,863Jul 18 04:21 PM
Wise Robert GSVP, Corporate ControllerJul 14Sale48.1917,245830,97418,618Jul 18 04:21 PM
JURGENSEN WILLIAM GDirectorJul 08Option Exercise24.549,000220,860119,356Jul 08 04:51 PM
JURGENSEN WILLIAM GDirectorJul 08Sale47.884,636221,972114,720Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Option Exercise24.549,000220,86089,850Jul 08 04:50 PM
GOLDSTONE STEVEN FDirectorJul 07Option Exercise24.5481,1681,991,863191,922Jul 08 04:51 PM
GOLDSTONE STEVEN FDirectorJul 07Sale48.0441,4701,992,132150,452Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Sale48.104,607221,59785,243Jul 08 04:50 PM
Johri RajiveDirectorJul 06Option Exercise21.4715,000322,05051,259Jul 08 04:56 PM
Johri RajiveDirectorJul 06Sale47.5315,000712,87736,259Jul 08 04:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Option Exercise36.8936,6541,352,16655,272Jul 07 08:47 PM
Gehring JohnEVP and CFOJul 05Option Exercise34.58159,0575,499,729218,766Jul 07 08:56 PM
Gehring JohnEVP and CFOJul 05Sale48.14159,0577,657,06859,709Jul 07 08:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Sale48.1636,6541,765,27118,618Jul 07 08:47 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Option Exercise30.8912,992401,323118,541Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Sale46.3512,992602,179105,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Option Exercise24.7410,000247,400115,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Sale46.2510,000462,500105,549Apr 13 04:51 PM
McGough Thomas MPresident, Consumer FoodsApr 07Option Exercise26.1560,0001,569,000116,341Apr 11 04:50 PM
McGough Thomas MPresident, Consumer FoodsApr 07Sale46.0060,0002,760,00056,341Apr 11 04:50 PM
GILD Gilead Sciences Inc. daily Stock Chart
Gilead Sciences Inc.
IndexS&P 500 P/E6.78 EPS (ttm)10.78 Insider Own0.30% Shs Outstand1.32B Perf Week-3.21%
Market Cap96.65B Forward P/E6.77 EPS next Y10.80 Insider Trans-17.45% Shs Float1.31B Perf Month-2.37%
Income15.08B PEG- EPS next Q2.62 Inst Own76.20% Short Float1.02% Perf Quarter0.66%
Sales31.58B P/S3.06 EPS this Y62.00% Inst Trans0.16% Short Ratio1.40 Perf Half Y-14.63%
Book/sh12.76 P/B5.73 EPS next Y-5.83% ROA29.30% Target Price95.29 Perf Year-19.63%
Cash/sh9.27 P/C7.88 EPS next 5Y-2.31% ROE93.70% 52W Range70.38 - 101.25 Perf YTD2.04%
Dividend1.88 P/FCF6.50 EPS past 5Y48.30% ROI45.90% 52W High-27.83% Beta1.12
Dividend %2.57% Quick Ratio1.80 Sales past 5Y32.60% Gross Margin86.50% 52W Low3.83% ATR1.40
Employees8000 Current Ratio1.90 Sales Q/Q-9.60% Oper. Margin60.80% RSI (14)43.38 Volatility1.75% 1.75%
OptionableYes Debt/Eq1.60 EPS Q/Q-18.70% Profit Margin47.70% Rel Volume0.86 Prev Close73.36
ShortableYes LT Debt/Eq1.56 EarningsFeb 07 AMC Payout16.40% Avg Volume9.56M Price73.07
Recom2.20 SMA20-1.59% SMA50-1.29% SMA200-9.08% Volume8,218,400 Change-0.40%
Nov-14-16Initiated Stifel Buy $100
Nov-08-16Initiated Mizuho Buy $88
Nov-02-16Reiterated RBC Capital Mkts Outperform $95 → $90
Oct-25-16Reiterated Jefferies Buy $93 → $95
Oct-03-16Reiterated RBC Capital Mkts Outperform $105 → $95
Sep-27-16Downgrade Leerink Partners Outperform → Mkt Perform $112 → $94
Sep-12-16Initiated Berenberg Buy $112
Sep-06-16Upgrade Jefferies Hold → Buy
Jul-29-16Downgrade Argus Buy → Hold
Jul-26-16Reiterated RBC Capital Mkts Outperform $120 → $105
Jul-26-16Downgrade Needham Buy → Hold
Jun-01-16Initiated Gabelli & Co Buy $109
Apr-29-16Reiterated UBS Buy $130 → $118
Apr-29-16Downgrade Maxim Group Buy → Hold
Mar-16-16Reiterated Leerink Partners Outperform $130 → $127
Feb-25-16Initiated Citigroup Buy $110
Feb-12-16Reiterated Maxim Group Buy $137 → $115
Feb-03-16Reiterated RBC Capital Mkts Outperform $130 → $120
Feb-03-16Reiterated Piper Jaffray Overweight $134 → $114
Feb-03-16Reiterated Oppenheimer Outperform $124 → $120
Jan-16-17 07:27AM  Is Donald Trump Big Pharma's Worst Nightmare? at Motley Fool
Jan-15-17 11:56AM  Should Investors Bet on Gilead Sciences Version 3.0? at Motley Fool
Jan-14-17 07:59AM  Donald Trump Just Leveled Drug Companies With These 4 Words at Motley Fool
Jan-12-17 12:35PM  Gileads Hepatitis B Drug Vemlidy Approved In EU at Investopedia
11:40AM  Gilead Sciences to Focus on NASH and HIV Drugs at Investopedia
09:43AM  Gilead Sciences: Time for Some M&A Flexibility? at
09:35AM  Biotech Short Sellers Run for Cover
08:40AM  Is the Options Market Predicting a Spike in Gilead Sciences (GILD) Stock?
07:47AM  Gilead (GILD) HBV Drug Vemlidy Receives European Approval
Jan-11-17 05:15PM  Stock Market Roundup Jan. 11: Health Sector Lower on Trump "Murder" Comment
05:01PM  Is Trump the biggest risk to his own rally?
03:46PM  Gilead Sciences: The M&A Question at
01:39PM  Andersen: Take Trump seriously, but not literally
01:26PM  Trump's Comments Are Big Pharma's Nightmare at Forbes
12:26PM  Trump's Comments Are Big Pharma's Nightmare
08:01AM  This Stumbling Biotech Stock Still Has a Lot of Promise at Kiplinger
06:53AM  European Commission Grants Marketing Authorization for Gileads Vemlidy® (Tenofovir Alafenamide, TAF) for the Treatment of Chronic Hepatitis B Virus Infection Business Wire
Jan-10-17 05:59PM  Final Trade: GILD, GM & more
05:07PM  Gilead CEO: M&A is top of mind for us this year
01:40PM  Will This Cure What Ails Valeant Pharmaceuticals? at Motley Fool
12:59PM  Todd Hagopian's Top Biotech Takeover Targets For 2017 at Forbes
12:10PM  10 Best Stocks for Retired Investors at Kiplinger
10:54AM  Is This the Solution to Gilead Sciences' Woes? at Motley Fool
10:54AM  4 Things Gilead Sciences' CEO Says to Expect in 2017 at Motley Fool
10:41AM  Top Biotech Resolutions for 2017 at Motley Fool
10:19AM  Gilead Sciences: How Soon is Now? at
09:00AM  Gilead Awards More Than $22 Million in Grants to Support HIV Cure Research Business Wire
08:35AM  Jefferies Has 5 Top Biotech Stocks to Buy for 2017
Jan-09-17 06:05PM  The 10 Worst Stocks in the Nasdaq in 2016 at Motley Fool
05:41PM  So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
04:24PM  2017 J.P. Morgan Healthcare Conference Roundup at Motley Fool
03:55PM  Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference
12:58PM  Why Ariad Pharmaceuticals Stock Soared Today at Motley Fool
09:30AM  The Zacks Analyst Blog Highlights: Gilead Sciences, Pepsi, United Parcel Services, Twitter and Stanley Black & Decker
Jan-08-17 02:13PM  What If You Considered Gilead Sciences a Start-Up? at Motley Fool
02:00PM  3 Takeover Candidates in the Drug Space
Jan-06-17 12:59PM  Top Research Reports for Pepsi, UPS & Gilead Sciences
10:55AM  Biotech Investing: 3 Bold Predictions for 2017 at Motley Fool
10:28AM  Could Amgen's Patent Victory Be Bad For Medicine? at Forbes
06:04AM  Here's Why You Should Sell Gilead, PPG, 3 More Toxic Stocks Before It's Too Late
Jan-05-17 02:55PM  Gilead Sciences Inc.'s Biggest Failure in 2016 at Motley Fool
02:50PM  Gilead Sciences Must Answer to Investors After a Disappointing 2016
11:34AM  Federal Judge Orders State Provide Mumia Abu-Jamal With HCV Treatment by Gilead Sciences, Inc. (GILD) at Insider Monkey
10:00AM  Beaten-Down Gilead Is My Top 2017 Pick
08:24AM  Gilead Sciences, Inc. breached its 50 day moving average in a Bullish Manner : GILD-US : January 5, 2017
07:01AM  Why Gilead Sciences Lost a Staggering 29.2% In 2016 at Motley Fool
06:54AM  Is Biogen Playing With Fire? at Motley Fool
06:21AM  What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
Jan-04-17 05:19PM  Buy health care despite Obamacare battle?
03:29PM  [$$] Pennsylvania Is Ordered to Provide Hepatitis C Drug to Inmate at The Wall Street Journal
03:04PM  Untreated: Hepatitis C, America's Prison Epidemic at MarketWatch
01:42PM  Gilead Sciences Is Surging -- Here's How to Trade It
11:24AM  Bulls following momentum in Gilead
11:23AM  [$$] The 'final nail in the coffin' for Aids? at Financial Times
10:00AM  Gilead Sciences: With New Hire, M&A Might Be on the Way at
06:04AM  Gilead poaches Novartis cancer specialist Riva
Jan-03-17 04:30PM  Alessandro Riva, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutic Area Head Business Wire
10:36AM  Whats the Outlook for Gilead Sciences?
10:28AM  9 Questions for Gilead Sciences at
10:08AM  Forget Gilead Sciences Inc.: These 2 Stocks Doubled Last Year at Motley Fool
09:06AM  The Impact of Gilead Sciences Other Products
07:36AM  Harvoni: Gilead Sciences Blockbuster HCV Drug
Jan-02-17 11:54AM  Biotech Stocks: What to Watch in 2017 at Motley Fool
10:36AM  Gilead Sciences Liver Disease Drugs Portfolio
07:37AM  New Products, Recent Developments for Gilead Sciences
Dec-31-16 12:10AM  [$$] News at Gilead Is Better but Not Good at The Wall Street Journal
Dec-30-16 06:05PM  What Factors Are Contributing to Gilead Sciences Growth?
04:16PM  Gilead Sciences Valuation Compared to Its Peers
03:36PM  January Will Feature Some Of The Market's Most Influential Events
02:31PM  4 Stocks for 2017
02:30PM  2016: Biotechs Tumultuous Year
11:45AM  [$$] News at Gilead Is Better but Not Good at The Wall Street Journal
Dec-29-16 05:00AM  This Army Vet Is Fighting Hep C With Big Pharmas Help at Bloomberg
Dec-28-16 02:33PM  Spring Bank Pharmaceuticals Inc (SBPH) An Ace Up Gilead Sciences, Inc. (GILD)s Sleeve at Insider Monkey
12:28PM  Halftime traders' 2017 playbook: Jon & Pete
10:10AM  Biotech Short Interest Sinks
09:52AM  2 Incredibly Cheap Dividend Stocks at Motley Fool
07:36AM  Whats Behind Amgens Discounted Valuation?
Dec-27-16 11:00AM  Biotech Poised for Rebound
09:41AM  Gilead Sciences: Time to Act Like Incyte? at
Dec-26-16 05:00PM  Gilead Sciences to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9 Business Wire
07:07AM  Will 2017 Be Gilead Sciences Inc.'s Worst Year Yet? at Motley Fool
Dec-24-16 08:15PM  Apple Inc, Gilead and Alphabet Inc: Can Analysts Predict Two Years Into The Future? at Insider Monkey
11:42AM  3 Great Income Stocks That Could Double Their Dividends at Motley Fool
08:06AM  The Most Likely Incyte Acquisition Deal for 2017? at Motley Fool
12:01AM  [$$] For Stocks, All's Calm, All's Brightfor Now at
Dec-23-16 02:32PM  Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider at Insider Monkey
02:00PM  Spring Bank (SBPH) Inks 3rd Collaboration Agreement
Dec-22-16 07:58PM  Cramer's lightning round: With no growth,this company must make an acquisition at CNBC
06:14PM  Health Care Companies Showing Good Defensive Potential
05:52PM  Biotech buying opportunity?
11:20AM  What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
11:08AM  GILD Stock: Can Gilead Sciences, Inc (GILD) Turn Around Its HCV Sales? at Insider Monkey
11:07AM  Will 2017 Be Gilead Sciences Inc.'s Worst Year Yet? at Motley Fool
10:42AM  How Alexion Pharmaceuticals Could Double in 2017 at
09:24AM  2016 Was a Terrible Year for Biotech but the Tweets Were on Point
08:06AM  5 Steps To Buying Biotech Stocks at Motley Fool
Dec-21-16 04:17PM  Celgene Expects Strong Revenue Growth in 2016
03:52PM  Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys at Motley Fool
01:46PM  [$$] What Gilead's True Believers Should Do Now at
Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company's products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARTIN JOHN CExecutive ChairmanJan 03Option Exercise21.5873,3371,582,2463,204,433Jan 05 03:39 PM
MARTIN JOHN CExecutive ChairmanJan 03Sale73.5973,3375,396,9713,131,096Jan 05 03:39 PM
MARTIN JOHN CExecutive ChairmanDec 01Option Exercise16.40100,0001,639,5003,231,096Dec 05 12:54 PM
WILSON GAYLE EDirectorDec 01Option Exercise0.002,1470107,486Dec 05 07:59 PM
MARTIN JOHN CExecutive ChairmanDec 01Sale73.33100,0007,332,8703,131,096Dec 05 12:54 PM
MADIGAN JOHN WDirectorNov 18Option Exercise20.71105,0002,174,025121,761Nov 22 02:45 PM
MADIGAN JOHN WDirectorNov 18Sale74.86105,0007,860,05916,761Nov 22 02:45 PM
Alton Gregg HEVP Comm&Acs ALA, Corp&Med AffNov 09Sale79.0010,000790,000122,964Nov 14 01:03 PM
MARTIN JOHN CExecutive ChairmanNov 01Option Exercise16.40100,0001,639,5003,231,096Nov 03 06:10 PM
MARTIN JOHN CExecutive ChairmanNov 01Sale73.76100,0007,376,0463,131,096Nov 03 06:10 PM
MARTIN JOHN CExecutive ChairmanOct 03Option Exercise16.40100,0001,639,5003,231,096Oct 05 12:52 PM
MARTIN JOHN CExecutive ChairmanOct 03Sale77.63100,0007,762,9613,131,096Oct 05 12:52 PM
Alton Gregg HEVP Comm&Acs ALA, Corp&Med AffSep 22Sale81.845,000409,220132,964Sep 26 04:54 PM
MILLIGAN JOHN FPresident and CEOSep 06Option Exercise20.7470,0001,451,8001,128,963Sep 08 01:35 PM
MILLIGAN JOHN FPresident and CEOSep 06Sale77.7470,0005,442,0801,058,963Sep 08 01:35 PM
MARTIN JOHN CExecutive ChairmanSep 01Option Exercise16.40100,0001,639,5003,231,096Sep 06 02:40 PM
MARTIN JOHN CExecutive ChairmanSep 01Sale77.48100,0007,748,3633,131,096Sep 06 02:40 PM
Lofton Kevin EDirectorAug 24Sale81.973,500286,8990Aug 25 05:05 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Option Exercise39.132,00078,25564,305Aug 03 04:48 PM
MARTIN JOHN CExecutive ChairmanAug 01Option Exercise16.40100,0001,639,5004,119,727Aug 03 04:51 PM
MILLIGAN JOHN FPresident and CEOAug 01Option Exercise20.7470,0001,451,8001,128,963Aug 03 04:53 PM
MILLIGAN JOHN FPresident and CEOAug 01Sale70.9470,0004,965,5901,058,963Aug 03 04:53 PM
MARTIN JOHN CExecutive ChairmanAug 01Sale80.50100,0008,049,7854,019,727Aug 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Sale79.812,000159,62062,305Aug 03 04:48 PM
Carter Paul RutherfordEVP Commercial OpsJul 31Option Exercise0.002,500063,622Aug 02 04:43 PM
MILLIGAN JOHN FPresident and CEOJul 05Option Exercise16.40112,0001,836,2401,170,963Jul 07 02:50 PM
MILLIGAN JOHN FPresident and CEOJul 05Sale84.33112,0009,444,9211,058,963Jul 07 02:50 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Option Exercise24.912,00049,81063,122Jul 06 01:26 PM
MARTIN JOHN CExecutive ChairmanJul 01Option Exercise16.40100,0001,639,5004,119,727Jul 06 01:28 PM
MARTIN JOHN CExecutive ChairmanJul 01Sale84.73100,0008,472,5234,019,727Jul 06 01:28 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Sale83.122,000166,25061,122Jul 06 01:26 PM
MILLIGAN JOHN FPresident and CEOJun 06Option Exercise16.40112,0001,836,2401,170,963Jun 08 06:59 PM
MILLIGAN JOHN FPresident and CEOJun 06Sale86.94112,0009,736,7791,058,963Jun 08 06:59 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Option Exercise24.912,00049,81063,122Jun 03 04:46 PM
MARTIN JOHN CExecutive ChairmanJun 01Option Exercise16.40100,0001,639,5004,119,727Jun 03 04:51 PM
MARTIN JOHN CExecutive ChairmanJun 01Sale86.72100,0008,671,9504,019,727Jun 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Sale87.022,000174,04061,122Jun 03 04:46 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Option Exercise33.8857,0921,934,021118,214Jun 02 04:35 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Sale86.8557,0924,958,60061,122Jun 02 04:35 PM
MARTIN JOHN CExecutive ChairmanMay 02Option Exercise16.40100,0001,639,5004,119,727May 04 02:44 PM
MILLIGAN JOHN FPresident and CEOMay 02Option Exercise16.40112,0001,836,2401,170,963May 04 02:49 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Option Exercise39.132,00078,25563,122May 04 04:23 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Sale88.722,000177,44861,122May 04 04:23 PM
MILLIGAN JOHN FPresident and CEOMay 02Sale87.71112,0009,823,9541,058,963May 04 02:49 PM
MARTIN JOHN CExecutive ChairmanMay 02Sale87.82100,0008,781,6944,019,727May 04 02:44 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Option Exercise26.9935,874968,239177,964Apr 21 01:28 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Sale100.0140,0004,000,574137,964Apr 21 01:28 PM
MILLIGAN JOHN FPresident and CEOApr 04Option Exercise16.40112,0001,836,2401,170,963Apr 05 07:30 PM
MILLIGAN JOHN FPresident and CEOApr 04Sale94.59112,00010,593,9041,058,963Apr 05 07:30 PM
MARTIN JOHN CExecutive ChairmanApr 01Option Exercise16.40100,0001,639,5004,119,727Apr 05 07:49 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Option Exercise24.912,00049,81063,122Apr 05 06:36 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Sale91.342,000182,68061,122Apr 05 06:36 PM
MARTIN JOHN CExecutive ChairmanApr 01Sale93.24100,0009,323,5074,019,727Apr 05 07:49 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Sale91.235,000456,158142,090Apr 05 07:45 PM
Alton Gregg HEVP, Corp & Med AffairsMar 14Sale90.005,000450,000147,090Mar 15 07:31 PM
MARTIN JOHN CChairman and CEOMar 01Option Exercise16.40100,0001,639,5004,119,727Mar 03 02:47 PM
MILLIGAN JOHN FPresident, COO and DirectorMar 01Option Exercise16.40112,0001,836,2401,170,963Mar 03 02:54 PM
Carter Paul RutherfordEVP Commercial OpsMar 01Option Exercise24.912,00049,81063,122Mar 03 03:10 PM
Carter Paul RutherfordEVP Commercial OpsMar 01Sale87.902,000175,80061,122Mar 03 03:10 PM
MILLIGAN JOHN FPresident, COO and DirectorMar 01Sale87.79112,0009,832,9951,058,963Mar 03 02:54 PM
MARTIN JOHN CChairman and CEOMar 01Sale88.58100,0008,857,8544,019,727Mar 03 02:47 PM
Washington Robin LEVP, CFOFeb 16Sale90.726,250567,00084,688Feb 18 07:59 PM
MARTIN JOHN CChairman and CEOFeb 01Option Exercise16.40100,0001,639,5004,048,066Feb 03 05:43 PM
Carter Paul RutherfordEVP Commercial OpsFeb 01Option Exercise39.142,00078,27150,783Feb 03 05:42 PM
Carter Paul RutherfordEVP Commercial OpsFeb 01Sale82.322,000164,64048,783Feb 03 05:42 PM
MARTIN JOHN CChairman and CEOFeb 01Sale83.42100,0008,342,4753,948,066Feb 03 05:43 PM
V Visa Inc. daily Stock Chart
Visa Inc.
IndexDJIA S&P500 P/E39.33 EPS (ttm)2.06 Insider Own0.10% Shs Outstand2.33B Perf Week-1.27%
Market Cap189.34B Forward P/E21.08 EPS next Y3.85 Insider Trans-25.33% Shs Float1.83B Perf Month2.49%
Income5.93B PEG2.49 EPS next Q0.78 Inst Own93.50% Short Float2.21% Perf Quarter-0.65%
Sales15.08B P/S12.55 EPS this Y-19.60% Inst Trans0.00% Short Ratio3.87 Perf Half Y4.06%
Book/sh11.53 P/B7.04 EPS next Y17.23% ROA10.00% Target Price94.55 Perf Year10.82%
Cash/sh3.83 P/C21.18 EPS next 5Y15.80% ROE20.00% 52W Range65.62 - 83.78 Perf YTD4.04%
Dividend0.66 P/FCF51.16 EPS past 5Y9.90% ROI13.60% 52W High-3.12% Beta0.99
Dividend %0.81% Quick Ratio1.80 Sales past 5Y10.40% Gross Margin- 52W Low23.70% ATR1.05
Employees11300 Current Ratio1.80 Sales Q/Q19.30% Oper. Margin52.30% RSI (14)59.71 Volatility1.11% 1.14%
OptionableYes Debt/Eq0.58 EPS Q/Q6.80% Profit Margin39.30% Rel Volume0.69 Prev Close81.37
ShortableYes LT Debt/Eq0.58 EarningsFeb 02 AMC Payout22.60% Avg Volume10.50M Price81.17
Recom1.90 SMA202.11% SMA501.96% SMA2002.22% Volume7,287,000 Change-0.25%
Dec-15-16Upgrade BofA/Merrill Neutral → Buy
Dec-05-16Upgrade Guggenheim Neutral → Buy
Oct-25-16Reiterated Stifel Buy $94 → $93
Oct-25-16Reiterated RBC Capital Mkts Outperform $87 → $89
Oct-25-16Downgrade Guggenheim Buy → Neutral
Jul-22-16Reiterated Stifel Buy $86 → $91
Jun-06-16Resumed JP Morgan Overweight $88
Apr-20-16Reiterated Sun Trust Rbsn Humphrey Buy $85 → $100
Apr-15-16Initiated Compass Point Neutral $80
Feb-11-16Downgrade BofA/Merrill Buy → Neutral
Dec-17-15Initiated Sterne Agee CRT Buy
Dec-16-15Initiated UBS Buy $90
Nov-03-15Reiterated RBC Capital Mkts Outperform $82 → $91
Oct-22-15Resumed Wells Fargo Outperform
Oct-19-15Reiterated Oppenheimer Outperform $81 → $85
Aug-20-15Reiterated Barclays Overweight $80 → $85
Jul-24-15Reiterated Topeka Capital Markets Hold $66 → $70
Jul-24-15Reiterated RBC Capital Mkts Outperform $79 → $82
Jul-24-15Reiterated FBR Capital Mkt Perform $70 → $80
Jul-20-15Reiterated Oppenheimer Outperform $73 → $81
Jan-16-17 06:05PM  How AXPs US Business Continues to Be Challenging in 4Q16
03:02PM  David Rolfe Comments on Visa
11:41AM  David Rolfe's Wedgewood Partners 4th Quarter Letter: Changing of the Guard
Jan-15-17 08:07AM  3 Financial Stocks With 30% Upside In Trump's First Year at Forbes
Jan-13-17 06:02PM  Dow 30 Stock Roundup: American Express Buys InAuth, Visa Inks Deal with Wal-Mart
04:57PM  Visa: 2016 strongest holiday shopping season in 5 years
Jan-12-17 10:05PM  Square Inc's Best Moves in 2016 at Motley Fool
12:20PM  Too Many Slices In The Pizza Pie! What's Behind Recent Pizza Promotions?
08:10AM  Amazon Offers Chase Credit Card Intended for Prime Members
Jan-10-17 11:35AM  U.S. top court grapples with credit card surcharge law dispute Reuters
10:23AM  Costco Knows Its Perfect Customer at Motley Fool
Jan-09-17 04:55PM  Can Square Generate Substantial Returns in 2017?
04:21PM  Visa, MasterCard, Global Payments Near Buy Range: Investing Action Plan
09:30AM  EMCORE, Opus Bank, Visa and Wal-Mart Stores Holding highlighted as Zacks Bull and Bear of the Day
08:51AM  This Stock Prevented The Dow From Hitting Key Milestone at Forbes
08:40AM  3 Stocks You Can Buy Cheaper Than Warren Buffett Did at Kiplinger
Jan-08-17 10:20AM  The 3 Top Dow Stocks From 10,000 to 20,000 at Motley Fool
Jan-07-17 09:45AM  The Bull-Bear Case for DJIA Financial Stocks in 2017: Amex, Goldman Sachs, JPMorgan, Visa, Travelers
Jan-06-17 07:10PM  2 Numbers PayPal Investors Should Watch at Motley Fool
05:26PM  Final Trade: MON, V & more
05:05PM  Visa Inks Deal with Wal-Mart, Lifts Credit Card Ban in Canada
04:22PM  10 Financial Stocks to Devour Before Trump Rally Sends Them Soaring
04:03PM  After Dow 19,999: Five Financial Stocks To Own In 2017 at Forbes
11:08AM  Visa, Inc. Value Analysis (NYSE:V) : January 6, 2017
Jan-05-17 06:00PM  Walmart Canada, Visa reach deal after fee dispute
06:00PM  Wal-Mart Ends Threat to Ban Visa Credit Cards Across Canada at Bloomberg
02:01PM  Honda and Visa Demonstrate In-vehicle Payments with Gilbarco and IPS Group at 2017 CES PR Newswire
12:05PM  5 Reasons MasterCard Is A "Top Pick" at
08:15AM  Blog Coverage UK's Competition Regulator Raises Concern Over the Proposed Mastercard/VocaLink Deal Accesswire
08:01AM  Visa, Inc. breached its 50 day moving average in a Bullish Manner : V-US : January 5, 2017
Jan-04-17 01:24PM  4 Things Costco's CFO Wants Investors to Know at Motley Fool
Jan-03-17 04:05PM  Visa Inc. To Announce Fiscal First Quarter 2017 Financial Results on February 2, 2017 Business Wire
04:01PM  Nike, Verizon Lead DJIA Higher Tuesday
02:22PM  The 5 Worst Stocks in the Dow Jones in 2016 at Motley Fool
Dec-30-16 12:58PM  Top trades for the New Year
07:00AM  Undervalued Visa Is Winning the Payment Wars
Dec-28-16 12:44PM  2016 retailer scorecard
07:00AM  Financials: What Will Really Drive Interest Rates? at Morningstar
Dec-27-16 03:58PM  ETFs are expanding into organic farming and other new trends at CNBC
03:52PM  Blockchain, Explained: How It Could Impact A Wide Range Of Industries
Dec-25-16 01:07PM  Is a Costco Executive Membership Worth an Extra $55 a Year? at Motley Fool
Dec-23-16 11:13AM  Stocks Quiet Ahead of Christmas Holiday; Apple, Microsoft Slip On Dow
09:05AM  What Can You Expect of Visa, MasterCard, and Amex in 2017?
07:36AM  Understanding Visas and MasterCards Higher Valuations
Dec-22-16 10:37AM  How Payment Processors Are Muscling up on the Partnership Front
Dec-21-16 06:40PM  Cramer preps for a major Costco comeback at CNBC
06:25PM  Cramer preps for a major Costco comeback
02:48PM  RBC Capital's opportunities in equity for 2017
11:25AM  Apple Inc. (AAPL), Alibaba, Amazon & More: Tiger Cubs Like These Stocks at Insider Monkey
09:18AM  Why Visa, MasterCard Are More Attractive, Plus Jim Cramer's Take
Dec-20-16 09:33AM  Visa (V) Teams with Deskera on Software as a Service
09:25AM  Costco Wholesale Corporation's Best Move in 2016 at Motley Fool
12:01AM  Deskera Partners With Visa on SaaS PR Newswire
Dec-19-16 10:09AM  Does Visa Pass Warren Buffett's Test? at Motley Fool
09:28AM  Payment Data Systems (PYDS) A Small Cap FinTech Growth Opportunity
Dec-17-16 08:50PM  Chinese Buying Insurance in Hong Kong Said to Face Further Curbs
Dec-16-16 04:01PM  Intel, Caterpillar Sink DJIA on Friday
11:15AM  Small Caps, Blue Chips Up While S&P, Nasdaq Struggle For Gains
11:12AM  Unpacking Visa and Mastercard's tokenization deal
10:11AM  Costco Rewards Card Offers What People Want at Motley Fool
09:03AM  Stocks With the Potential to Propel Dow Beyond 20K
08:04AM  Mega stocks' mega potential
Dec-15-16 08:04PM  Why Trumponomics Makes The Fed Less Important at Forbes
01:38PM  Take A Lesson From Drug Dealers To Make Your Online Shopping Safer
01:35PM  Mastercard and Visa Stock Upgraded: 2 Final "Trump Trades"? at Motley Fool
12:17PM  Cash or Credit? Visa Needs to Prove Itself on the Charts
11:58AM  Winners since Dow 10K
07:11AM  Visa upgraded by BofA/Merrill
Dec-14-16 07:00PM  Cramer Remix: Why the market didnt tank after the Feds ...
05:29PM  TSX Movers: Valeant, Merus Labs, Teck Resources
05:01PM  Canada Eyes Expanding Fast-Track Work Visa Beyond Startups at Bloomberg
06:00AM  Maximizing a Smaller Portfolio for Retirement at Morningstar
Dec-13-16 03:57PM  Costco Wholesale Corporation's Most Disappointing Product in 2016 at Motley Fool
01:03PM  Stocks boosting Dow towards 20K since the election
Dec-12-16 09:01AM  Buyout groups prepare final bids for payments group Concardis - sources
Dec-09-16 02:09PM  Credit cards and the Trump rally
Dec-08-16 10:30AM  Costco: So That's Why It Dumped American Express at
08:55AM  Use Charts to Trade VeriFone and Profit From Electronic Payments Sector
07:28AM  Stocks close at new heights as investors shake off Trump-inspired health-care woes at MarketWatch
Dec-07-16 07:28PM  Costco Keeps Climbing on Membership Revenue Growth, Earnings Gains at Motley Fool
06:01PM  5 consumer stocks set to cash in this holiday season at MarketWatch
04:01PM  Nike, Home Depot Dominate DJIA on Wednesday
12:00PM  A Mixed Reading on Ciena Into Earnings at TheStreet
Dec-06-16 04:35PM  Cryder Capital Boosts Bets On Alphabet (GOOG), Credit Cards, Health Stocks at Insider Monkey
01:40PM  Billionaires Love These Consumer Stocks at Insider Monkey
12:57PM  Stocks tripped up by Trump
11:35AM  The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards? at 24/7 Wall St.
10:11AM  Alibaba Banks On Europe at
07:27AM  Visa Stock Upgrade by Guggenheim (V, MA) at Investopedia
Dec-05-16 04:46PM  Dow closes at all-time high as Trump rally marches on at MarketWatch
01:29PM  [$$] Visa: Earnings Power and An Attractive Valuation at
12:53PM  Techs Pace Early Gains; Apple Acknowledges Automation Interest
11:34AM  Visa: Better Than MasterCard, Cheaper Too at
09:42AM  Must-See Charts For The 3 Dow Stocks Down More Than 5% This Year at Forbes
08:57AM  Morning Movers: Chesapeake Energy Jumps; Nike, McDonald's Rise on Upgrades at
08:13AM  [$$] Bank card groups to lose China market share at Financial Times
Dec-04-16 02:02PM  Billionaire Dan Loeb Buys Back Into Apple, Adds Alibaba, Visa, More at Insider Monkey
Dec-02-16 09:30AM  The Zacks Analyst Blog Highlights: Visa, Procter & Gamble, Coca-Cola and Cisco Systems
08:46AM  Visa (V) to Buy Cardinal to Boost Security in Online Services
12:25AM  [$$] Card Companies Give Gas Stations Three Extra Years to Install Chip Technology at The Wall Street Journal
Visa Inc. operates as a payments technology company worldwide. The company facilitates commerce through the transfer of value and information among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants. The company also offers gateway services for merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. In addition, it provides digital products, including Visa Checkout that offers consumers an expedited and secure payment experience for online transactions; and Visa Direct, a push payment product platform, which facilitates payer-initiated transactions that are sent directly to the Visa account of the recipient, as well as Visa token service that replaces the card account numbers from the transaction with a token. Further the company offers corporate (travel) and purchasing card products, as well as value-added services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company has a strategic partnership agreement with Oman Arab Bank to convert the bank's current electron cards to chip-and-PIN debit cards. Visa Inc. was incorporated in 2007 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCINERNEY RYANPRESIDENTNov 08Sale82.9218,5001,534,09038,321Nov 09 07:06 PM
SCHARF CHARLES WCHIEF EXECUTIVE OFFICEROct 28Option Exercise40.05772,91230,956,4591,006,756Oct 28 08:00 PM
SCHARF CHARLES WCHIEF EXECUTIVE OFFICEROct 28Sale82.65772,91263,883,109233,844Oct 28 08:00 PM
RICHEY ELLENVICE CHAIR RISK & PUB POLICYFeb 10Sale70.0039,3482,754,36049,996Feb 11 05:13 PM
PPG PPG Industries, Inc. daily Stock Chart
PPG Industries, Inc.
IndexS&P 500 P/E32.38 EPS (ttm)2.98 Insider Own0.38% Shs Outstand265.50M Perf Week0.76%
Market Cap25.57B Forward P/E15.20 EPS next Y6.34 Insider Trans-4.80% Shs Float262.42M Perf Month-0.75%
Income801.00M PEG4.13 EPS next Q1.19 Inst Own72.80% Short Float1.18% Perf Quarter5.00%
Sales14.95B P/S1.71 EPS this Y30.50% Inst Trans0.32% Short Ratio1.79 Perf Half Y-11.14%
Book/sh18.89 P/B5.10 EPS next Y7.30% ROA5.20% Target Price110.20 Perf Year4.56%
Cash/sh3.67 P/C26.23 EPS next 5Y7.84% ROE17.20% 52W Range87.00 - 115.63 Perf YTD1.65%
Dividend1.60 P/FCF365.33 EPS past 5Y17.20% ROI15.80% 52W High-16.70% Beta1.38
Dividend %1.66% Quick Ratio1.10 Sales past 5Y2.70% Gross Margin45.20% 52W Low10.71% ATR1.34
Employees46600 Current Ratio1.40 Sales Q/Q1.70% Oper. Margin8.30% RSI (14)51.06 Volatility1.23% 1.27%
OptionableYes Debt/Eq0.88 EPS Q/Q-149.50% Profit Margin5.90% Rel Volume0.69 Prev Close96.87
ShortableYes LT Debt/Eq0.75 EarningsJan 19 BMO Payout46.10% Avg Volume1.73M Price96.32
Recom2.00 SMA200.53% SMA500.42% SMA200-5.95% Volume1,217,400 Change-0.57%
Jan-09-17Downgrade Citigroup Buy → Neutral
Dec-13-16Downgrade RBC Capital Mkts Outperform → Sector Perform $105 → $101
Oct-25-16Downgrade Argus Buy → Hold
Oct-21-16Downgrade Goldman Buy → Neutral
Oct-11-16Reiterated RBC Capital Mkts Outperform $125 → $106
Oct-11-16Downgrade Deutsche Bank Buy → Hold $122 → $100
Jul-26-16Upgrade Seaport Global Securities Accumulate → Buy $125 → $130
Jun-23-16Upgrade Longbow Neutral → Buy
Mar-22-16Resumed Credit Suisse Outperform
Jan-22-16Reiterated Deutsche Bank Buy $110 → $105
Jan-05-16Initiated Seaport Global Securities Accumulate $115
Nov-25-15Reiterated RBC Capital Mkts Outperform $115 → $129
Oct-16-15Upgrade UBS Neutral → Buy $122
Oct-16-15Reiterated Barclays Equal Weight $120 → $115
Oct-12-15Upgrade Goldman Neutral → Buy $107 → $113
Sep-14-15Reiterated RBC Capital Mkts Outperform $126 → $115
Sep-08-15Reiterated RBC Capital Mkts Outperform $145 → $126
Jan-16-15Reiterated Argus Buy $238 → $271
Oct-17-14Reiterated RBC Capital Mkts Outperform $250 → $243
Oct-09-14Initiated RBC Capital Mkts Outperform $250
Jan-16-17 04:05PM  PPG Industries: Analysts Recommendations ahead of Q4 Earnings
02:35PM  Why Analysts Expect PPG Industries Q4 Adjusted Earnings to Fall
12:40PM  PPG Industries 4Q16 Revenues: Why Analysts Are Bearish
07:22AM  What Lies Ahead for PPG Industries (PPG) in Q4 Earnings?
Jan-13-17 12:28PM  PPG sees call buying before earnings
Jan-10-17 11:54AM  PPG Industries, Inc. : PPG-US: Dividend Analysis : November 10th, 2016 (record date) : By the numbers : January 10, 2017
08:00AM  PPG to Highlight Automotive Coatings at 2017 NAIAS Business Wire
Jan-09-17 11:35AM  PPG Extends Its Presence in EMEA Region with DEUTEK Acquisition
09:23AM  PPG Industries downgraded by Citigroup
Jan-06-17 06:32AM  PPG Industries Closes Buyout of Romanian Paint Maker Deutek
06:04AM  Here's Why You Should Sell Gilead, PPG, 3 More Toxic Stocks Before It's Too Late
Jan-05-17 08:45AM  PPG Industries, Inc. breached its 50 day moving average in a Bullish Manner : PPG-US : January 5, 2017
08:11AM  PPG Completes Acquisition of Romanian Paint and Coatings Manufacturer DEUTEK Business Wire
Jan-02-17 07:37AM  Analyzing PPG Industries 2016 Dividend
Dec-30-16 05:35PM  Whats Analysts Latest on PPG Industries?
03:53PM  PPG Industries Stock Price Is Still Under Pressure Post-3Q16
08:15AM  Blog Coverage PPG Sells the Plaka Business to Knauf Accesswire
Dec-29-16 07:36AM  RPM Internationals Valuations before Its Fiscal 2Q17 Results
06:09AM  PPG Industries Selling Plaka Plasterboard Business to Knauf
Dec-28-16 03:35PM  Will RPM International Beat Its 2Q16 EPS?
08:15AM  Post Earnings Coverage as Valspar Q4 Missed Market Estimates Accesswire
Dec-27-16 11:15AM  PPG Industries, Inc. Value Analysis (NYSE:PPG) : December 27, 2016
11:14AM  PPG Industries Disposes Plaka Plasterboard Business
Dec-23-16 08:11AM  PPG Reaches Agreement with Knauf for Sale of Plaka Plasterboard Business Business Wire
07:48AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : December 23, 2016
Dec-21-16 02:09PM  PPG Completes COLOURFUL COMMUNITIES Project at Whare Koa Mangere Community House in New Zealand Business Wire
02:09PM  PPG Completes COLORFUL COMMUNITIES Project at Whare Koa Mangere Community House in New Zealand Business Wire
Dec-20-16 03:12PM  PPG to Announce Fourth Quarter and Full-Year 2016 Results Jan. 19, 2017 Business Wire
Dec-12-16 01:05PM  H.B. Fuller Initiates Restructuring Program to Fuel Growth
12:20PM  ETFs with exposure to PPG Industries, Inc. : December 12, 2016
11:17AM  How PPG Industries Aims to Save $125 Million Per Year
09:24AM  PPG Industries Declares Restructuring Actions to Lower Costs
08:22AM  Blog Coverage Paint Manufacturer PPG Embarks on a Cost-Cutting Plan, Aims to Save $125 million Annually Accesswire
Dec-09-16 02:11PM  PPG INDUSTRIES INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities
08:20AM  PPG announces global restructuring at
07:59AM  [$$] PPG to Restructure to Reduce Costs at The Wall Street Journal
07:00AM  PPG Industries unveils latest restructuring, targeting $125 million in annual savings at MarketWatch
06:51AM  PPG Initiates Global Restructuring, Targeting $125 Million in Annual Savings Business Wire
Dec-08-16 05:07PM  PPG Industries (PPG) Launches Durastar Ultra-Cool Coatings
01:21PM  White is about to be replaced as the most popular car color at MarketWatch
Dec-07-16 10:11AM  PPG Foundation Donates $15,000 to Chicago Urban League for Project Ready Business Wire
09:13AM  PPG Industries Inks Deal to Distribute Sauereisen Products
Dec-06-16 09:42AM  PPG Industries Primer Coatings Picked by LOT Polish Airlines
08:06AM  Why Valuations for Sherwin-Williams Are Higher Than Its Peers
Dec-05-16 10:30AM  Strong Demand for PPG's Useful Products Make It a Good Investment
Dec-02-16 11:01AM  ETFs with exposure to PPG Industries, Inc. : December 2, 2016
Dec-01-16 04:58PM  PPG Industries' Homax Launches New Tough As Tile Product
07:40AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : December 1, 2016
Nov-30-16 01:17PM  HOMAX Brand by PPG Introduces New and Improved TOUGH AS TILE Product Business Wire
Nov-29-16 10:05AM  Pension Settlement Charges Weighed Heavily on PPG Industries
04:33AM  Is PPG Industries, Inc. (PPG) A Good Stock To Buy? at Insider Monkey
Nov-28-16 01:34PM  Positives and Negatives of LyondellBasells 3Q16 Earnings
Nov-23-16 10:14AM  3 Stocks That Turned $8,000 Into $90,400 (or More) in 26 Years at Motley Fool
08:17AM  PPG Industries' (PPG) Coatings Systems Selected by Airbus
Nov-22-16 06:33AM  PPG Wraps Up Sale of Interest in PFG Fiber Glass JVs
Nov-21-16 01:11PM  PPG Completes COLORFUL COMMUNITIES Project at Academy Prep Center Business Wire
01:04PM  PPG Completed Its Stake Sale in PFG Fiberglass Joint Venture
Nov-18-16 06:04PM  What Impact Will New Notes Have on PPG Industries Earnings?
05:04PM  Is PPG Industries Getting Aggressive with Increased Debt?
02:45PM  PPG Industries Unleashes Its Leverage Power with More Debt
12:50PM  McGarry of PPG to Present at 2016 Citi Basic Materials Conference Business Wire
08:11AM  PPG Completes Sale of Its Ownership Interest in PFG Fiber Glass Joint Ventures Business Wire
Nov-14-16 02:04PM  PPG Industries Now Completely Owns PPG Univer
11:19AM  New Strong Sell Stocks for November 14th
06:33AM  PPG Industries Buys Remaining Stake in Italian Coatings JV
Nov-13-16 04:35PM  Is DIY Giant Lowe's the Key to This $11 Billion Merger? at Motley Fool
Nov-11-16 07:11AM  PPG Acquires Remaining Interest in Italian Coatings Joint Venture Business Wire
Nov-10-16 02:11PM  PPG Earns R&D 100 Awards for Automotive, Aerospace Electrocoat Technologies Business Wire
10:47AM  LIQUID NAILS Brand FUZE*IT Adhesive by PPG Named Top 100 Product of 2016 by THIS OLD HOUSE Magazine Business Wire
10:04AM  Why Did the Chemours Chemical Solutions Segments Revenue Dip in 3Q16?
Nov-08-16 08:30AM  PPG Helps Build and Paint Bicycles for Children in Istanbul Through COLORFUL COMMUNITIES Project Business Wire
07:45AM  PPG Wins First-Ever Global Design Award from Groupe Renault Business Wire
Nov-07-16 04:06PM  A Quick Look at a Few Chemical Companies in 2016
03:50PM  Top 6 Vendors in the Waterborne Coatings Market From 2016 to 2020: Technavio Business Wire
Nov-03-16 03:57PM  PPG INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl
Nov-01-16 05:13PM  PPG Reaches Agreement to Acquire Romanian Paint and Coatings Manufacturer DEUTEK Business Wire
Oct-28-16 05:07PM  PPG INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
08:11AM  PPG Marks Completion of Silica Capacity Expansion at Delfzijl, Netherlands, Plant Business Wire
Oct-27-16 02:35PM  PPG Completes First Phase of Automotive Adhesives and Sealants Manufacturing Expansion Project in Mexico Business Wire
01:26PM  PPG Prices Offering of Euro-Denominated Senior Notes Business Wire
01:04PM  PPG INDUSTRIES INC Financials
Oct-26-16 08:04AM  How Did PPG Industries 3Q16 Performance Affect Its Valuation?
Oct-25-16 04:32PM  GM, Caterpillar Fall Below Buy Points As Industrial Giants Guide Low
02:54PM  ETFs with exposure to PPG Industries, Inc. : October 25, 2016
12:11PM  PPG Industries Declares Quarterly Dividend (PPG) at Investopedia
11:04AM  Analysts Post-3Q16 Recommendations for PPG Industries
10:04AM  PPG Industries 3Q16 Glass Net Income Doubles as Revenue Falls
09:07AM  PPG Announces Most Popular Automotive Colours for 2016 Business Wire
09:07AM  PPG Announces Most Popular Automotive Colors for 2016 Business Wire
08:04AM  Why did PPGs Industrial Coatings Revenue Rise in 3Q16?
Oct-24-16 05:53PM  CORRECTING and REPLACING PPG Announces Executive Appointments Business Wire
02:29PM  PPG Industries Downgraded at Goldman Sachs (PPG) at Investopedia
01:40PM  PPG Kansai Automotive Finishes Receives Nissan 2016 Regional Monozukuri Spirit Award Business Wire
11:04AM  Why Did PPGs Performance Coatings Revenue Fall in 3Q16?
10:09AM  PPG Industries, Inc. :PPG-US: Earnings Analysis: Q3, 2016 By the Numbers : October 24, 2016
10:05AM  Despite Lower Sales, PPGs 3Q16 Earnings Meet Expectations
08:06AM  PPG Industries Misses 3Q16 Revenue Estimates: Why?
08:00AM  CPI Aerostructures Selects PPG as Strategic Supplier for Vendor Managed Consumables Marketwired
Oct-21-16 04:25PM  PPG INDUSTRIES INC Files SEC form 10-Q, Quarterly Report
04:17PM  GE Cuts Revenue View After Q3 Miss But Sees Strong-Dollar Drag Easing
PPG Industries, Inc. manufactures and distributes coatings, specialty materials, and glass products. It operates in three segments: Performance Coatings, Industrial Coatings, and Glass. The Performance Coatings segment provides coatings products for automotive and commercial transport/fleet repair and refurbishing; light industrial and specialty coatings for signs; coatings, sealants, and transparencies for commercial, military, regional jet and general aviation aircraft, and transparent armor for specialty applications; and chemical management services. This segment also offers protective and marine coatings and finishes for the protection of metals and structures to metal fabricators and heavy duty maintenance contractors, as well as to the manufacturers of ships, bridges, and rail cars; architectural coatings used by painting and maintenance contractors, and consumers for decoration and maintenance of residential and commercial building structures; and purchased sundries to painting contractors and consumers. The Industrial Coatings segment provides adhesives and sealants for the automotive industry; metal pretreatments and related chemicals for industrial and automotive applications; precipitated silicas for tire, battery separator, and other markets; substrates used in radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards; organic light emitting diode materials for use in displays and lighting; optical lens materials and photochromic dyes for optical lenses and color-change products. The Glass segment produces flat and fiber glass for use in commercial and residential construction, wind energy, energy infrastructure, transportation, and electronics industries. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KNAVISH TIMOTHY MSr. VP, Automotive CoatingsAug 04Option Exercise63.749,300592,76219,506Aug 08 03:45 PM
KNAVISH TIMOTHY MSr. VP, Automotive CoatingsAug 04Sale104.089,300967,93110,206Aug 08 03:45 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Option Exercise65.7630,4502,002,24069,044Jul 28 10:15 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Sale106.6440,9504,367,01428,094Jul 28 10:15 AM
USHER THOMAS JDirectorApr 20Option Exercise0.001,09202,092Apr 22 03:30 PM
RICHENHAGEN MARTINDirectorApr 20Option Exercise0.001,092020,576Apr 22 03:25 PM
HOOPER MICHELE JDirectorApr 20Option Exercise0.001,092015,352Apr 22 03:16 PM
Sklarsky Frank SExecutive VP & CFOFeb 29Option Exercise0.0010,000024,467Mar 02 12:40 PM
BUNCH CHARLES EExecutive Chairman of BoardFeb 26Sale98.1746,2864,543,711732,911Mar 01 04:01 PM
RICHENHAGEN MARTINDirectorFeb 20Option Exercise0.001,750019,484Feb 23 08:44 AM
HOOPER MICHELE JDirectorFeb 20Option Exercise0.001,750014,260Feb 23 08:40 AM
BERGES JAMES GDirectorFeb 20Option Exercise0.001,750010,488Feb 23 08:20 AM
HON Honeywell International Inc. daily Stock Chart
Honeywell International Inc.
IndexS&P 500 P/E18.45 EPS (ttm)6.40 Insider Own0.10% Shs Outstand763.70M Perf Week-0.39%
Market Cap90.17B Forward P/E16.80 EPS next Y7.03 Insider Trans-47.12% Shs Float759.96M Perf Month-0.02%
Income4.97B PEG2.40 EPS next Q1.74 Inst Own75.90% Short Float0.51% Perf Quarter9.71%
Sales39.30B P/S2.29 EPS this Y13.30% Inst Trans-0.04% Short Ratio1.13 Perf Half Y0.13%
Book/sh25.13 P/B4.70 EPS next Y6.52% ROA9.70% Target Price129.45 Perf Year22.22%
Cash/sh11.29 P/C10.46 EPS next 5Y7.69% ROE26.70% 52W Range91.68 - 118.71 Perf YTD1.92%
Dividend2.66 P/FCF104.73 EPS past 5Y19.40% ROI16.00% 52W High-0.54% Beta0.94
Dividend %2.25% Quick Ratio0.90 Sales past 5Y3.60% Gross Margin31.90% 52W Low28.78% ATR1.37
Employees129000 Current Ratio1.20 Sales Q/Q2.00% Oper. Margin16.90% RSI (14)61.09 Volatility0.93% 1.13%
OptionableYes Debt/Eq0.83 EPS Q/Q0.00% Profit Margin12.60% Rel Volume0.87 Prev Close117.63
ShortableYes LT Debt/Eq0.50 EarningsJan 27 BMO Payout45.90% Avg Volume3.40M Price118.07
Recom1.80 SMA200.96% SMA503.21% SMA2003.93% Volume2,988,300 Change0.37%
Oct-10-16Reiterated RBC Capital Mkts Outperform $138 → $133
Oct-06-16Initiated Robert W. Baird Outperform $135
Apr-25-16Reiterated Stifel Buy $127 → $129
Apr-25-16Reiterated RBC Capital Mkts Outperform $121 → $122
Apr-18-16Reiterated Barclays Overweight $107 → $122
Feb-01-16Reiterated Stifel Buy $106 → $113
Dec-17-15Reiterated Oppenheimer Outperform $117 → $120
Nov-16-15Reiterated Barclays Overweight $103 → $104
Oct-20-15Reiterated Argus Buy $115 → $118
Oct-19-15Reiterated RBC Capital Mkts Outperform $121 → $120
Jul-31-15Reiterated Barclays Overweight $120 → $118
Jul-29-15Reiterated Barclays Overweight $115 → $120
Jul-21-15Reiterated Argus Buy $115 → $118
Jul-20-15Reiterated Stifel Buy $116 → $120
Jul-20-15Reiterated RBC Capital Mkts Outperform $116 → $122
May-15-15Reiterated Cowen Outperform $112 → $116
Jan-27-15Reiterated Argus Buy $106 → $115
Jan-22-15Initiated UBS Neutral $105
Dec-16-14Reiterated Stifel Buy $109 → $112
Nov-25-14Reiterated RBC Capital Mkts Outperform $105 → $116
Jan-16-17 12:40PM  Honeywell, Intel to Jointly Develop Internet of Things Solutions for Retailers and Logistics Providers PR Newswire
Jan-13-17 12:30PM  Honeywell International, Inc. : HON-US: Dividend Analysis : November 18th, 2016 (record date) : By the numbers : January 13, 2017
06:36AM  Can Honeywell Boost '17 Performance with Unique Products?
Jan-12-17 12:50PM  Honeywell Lightens Tactical Vests For Law Enforcement Officers By Up To 40 Percent PR Newswire
07:36AM  Why MMM Is Trading at a Premium Compared to Other Industrials
05:00AM  Honeywell And EAD Aerospace Boost In-Flight Connectivity For Airbus A319 With European Agency Certification PR Newswire
Jan-11-17 08:10PM  AdvanSix: Jim Cramer's Top Takeaways
07:58AM  15,000th Supemarket Refrigeration System Retrofitted With Honeywell's Lower-Global-Warming Refrigerant PR Newswire
07:37AM  How Is Honeywell Valued Compared to Peers?
Jan-10-17 12:05PM  What Do Analysts Recommend for Honeywell?
10:38AM  How Feds Rate Hike Will Affect Honeywells Pension Objectives
08:40AM  Why Honeywell Stock Saw a Muted Performance in December
08:30AM  Honeywell And Aereon To Leverage Industrial Internet of Things (IIoT) For Oil And Gas PR Newswire
Jan-09-17 01:24PM  3 Stocks Poised to Generate Way More Cash in 2017 at Motley Fool
09:06AM  Honeywell Names Que Thanh Dallara As Vice President, Commercial Excellence And Strategy PR Newswire
Jan-08-17 02:18PM  5 Trade Ideas for Monday: AIG, CME, Honeywell, McDonald's and Pfizer
Jan-06-17 09:41AM  Honeywell To Release Fourth Quarter Financial Results And Hold Its Investor Conference Call On Friday, January 27 PR Newswire
03:00AM  Top of the Phoenix Lists: Defense Contractors at
Jan-05-17 02:42PM  General Electric, Honeywell 'Safe Havens' As Economic Cycle Clock Resets, RBC Says
09:00AM  Know Your Home Better With Honeywell's Lyric Platform: Introducing The First-Ever Lyric Cameras, And Lyric Security Now Compatible With Apple® HomeKit PR Newswire
Jan-04-17 11:40AM  The Bullish View for Conglomerates in 2017: GE Over 3M and United Technologies
10:00AM  Safariland Uses Honeywell Spectra Shield® In New Protective Vests For Female Law Enforcement Officers PR Newswire
09:30AM  Aegion Corporation Announces Appointment of Rhonda Germany Ballintyn to Board of Directors GlobeNewswire
Dec-21-16 04:39PM  Alexion Announces Phase Two Trial Failure, Falls Slightly After Hours
03:00PM  Honeywell And Dover Energy Automation Collaborate To Offer Asset Integrity Management PR Newswire
12:36PM  The Case for Buying Honeywell International Inc. Stock at Motley Fool
10:21AM  Alfa Laval, Honeywell bid for air treatment firm Munters - sources Reuters
08:12AM  Defense Stock Roundup: Huntington Ingalls, Raytheon Win Big; Honeywell Offers Soft View
Dec-19-16 04:21PM  Instant Analysis: Honeywell International's 2017 Outlook at Motley Fool
12:49PM  Honeywell: It's the Quality, Not the Quantity at
09:47AM  Honeywell Could Struggle for More Growth
08:06AM  Honeywell Offers Tepid 2017 Guidance on Sluggish Demand
Dec-16-16 11:09PM  [$$] Honeywell Gives Tempered Outlook for 2017, Hurt By Slack Demand at The Wall Street Journal
08:27PM  Jim Cramer's 'Mad Money' Recap: Sloppiness Causing Investors to Lose Focus
07:50PM  $2.6B contract awarded for Sandia National Labs management
07:01PM  Cramer: Do Your Homework! Honeywell's Release This Morning Was Positive
06:10PM  Cramer's game plan: Santa rally could have legs next week at CNBC
06:00PM  Cramer's game plan: Santa rally could have legs next week
05:15PM  Honeywell in trouble?
04:36PM  Honeywell Guidance Weak, But Stock Erases Loss Amid Manufacturing Optimism
04:06PM  Stocks End Unsettled Quadruple Witching Session With Slight Losses
03:23PM  Industrials try to lower expectations: Should we take them seriously? at CNBC
12:57PM  [$$] Honeywell Gives Tempered Outlook for 2017, Hurt by Slack Demand at The Wall Street Journal
12:35PM  Oracle, Adobe React; Honeywell Hurts; Two Dividend Stocks To Consider
12:35PM  Oracle, Adobe React To Earnings; Two Dividend Stocks To Consider
11:48AM  Honeywell: Slightly Disappointing? at
11:36AM  Stocks Mixed as Oracle Weighs on Tech Sector
11:01AM  Those Who Sold Honeywell Down $10 Need to 'Be in Detention' for Life: More Squawk From Jim Cramer
09:55AM  Stocks to Watch: Oracle, Honeywell and DryShips at The Wall Street Journal
09:47AM  Honeywell falls on weak outlook, Gilead loses Merck patent dispute, Trivago goes public
09:00AM  US STOCKS-Wall St set to open higher; Dow closes in on 20,000
08:59AM  Honeywell Trims Guidance but Shares Retake Ground Lost in Pre-Open Trading
08:15AM  Investors wait for Dow 20,000 as Facebook fights fake news
07:01AM  Honeywell provides 2017 profit and sales outlook at MarketWatch
06:51AM  Honeywell says 4th-qtr earnings to be at low end of forecast
06:30AM  Honeywell Provides 2017 Outlook; Earnings Per Share Guidance Of $6.85 - $7.10 PR Newswire
06:25AM  Stocks to Watch: December 16, 2016
Dec-15-16 04:40PM  Defense Stock Roundup: Boeing Hikes Dividend, Lockheed Martin Wins Deals
Dec-14-16 09:27AM  Helen of Troy's (HELE) Kaz Launches New Ceramic Heaters
09:00AM  Ring in the Holidays With Honeywell's Battery-Powered and Plug-in Wireless Doorbells PR Newswire
Dec-13-16 04:21PM  Missing Phrase May Give Clue To Alexion Shake-Up, Analyst Says
09:00AM  Walmart Launches Online Destination for Last-Minute Shoppers
09:00AM  Honeywell And Air Methods Sign Agreement For Sky Connect Tracker PR Newswire
Dec-12-16 04:06PM  Alexion Tanks After CEO, CFO Unexpectedly Resign Amid Sales Probe
04:06PM  Intel, T-Mobile, Honeywell Make Barclays' Top Picks
02:03PM  HONEYWELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
11:06AM  Why Alexion Pharmaceuticals, Inc.'s Shareholders Lost $3 Billion Today at Motley Fool
08:00AM  Honeywell President and Chief Operating Officer Darius Adamczyk Elected To Company's Board of Directors PR Newswire
Dec-09-16 02:04PM  Risks and picks for the Trump rally
09:53AM  Peltz Can Do Better Than Honeywell at Bloomberg
Dec-08-16 01:23PM  What Prompted Trumps Sudden Boeing Tweet?
10:10AM  Honeywell's Transportation Systems Forecast Sees Global Annual Sales Of Turbocharged Vehicles Increasing 35 Percent By 2021 And Outpacing Total Industry CAGR 3 To 1 PR Newswire
08:00AM  Nobel Laureate Claude Cohen-Tannoudji Inspires Students To Pursue Their Passion For Science And Engineering At Brno University Of Technology, Czech Republic PR Newswire
Dec-07-16 03:35PM  Gabelli Downgrades Johnson Controls Stock to Hold
Dec-06-16 06:11PM  Honeywell confirms it will locate $19 million IT center at Midtown's 715 Peachtree at
10:00AM  KBR Continues to Face Macro Challenges: Should you Hold?
09:57AM  Delek Refining To Use Honeywell's Connected Performance Services To Improve Refinery Performance PR Newswire
09:48AM  United Technologies Corporation: a Hidden Value Stock at Motley Fool
Dec-05-16 09:30AM  The Zacks Analyst Blog Highlights: United Parcel Service, Honeywell, Lowe's, MasterCard and General Mills
Dec-01-16 06:20PM  What the Pros at Honeywell, Siemens Learned About Pruning Hedges
11:57AM  Should You Avoid Walgreens Boots Alliance Inc (WBA)? at Insider Monkey
Nov-30-16 08:30AM  Honeywell Control And Safety System Selected For Vital Natural Gas Pipeline In Turkey PR Newswire
05:07AM  Honeywell To Provide Advanced Navigation System To New British Armored Fighting Vehicles PR Newswire
Nov-29-16 07:00PM  Cramer Remix: why you shouldnt sell before year end
Nov-28-16 08:01AM  The Temperature is Rising on Honeywell: Bonus Idea
Nov-23-16 02:58PM  Honeywell International Inc. (HON): Hedge Funds Remain Cautious at Insider Monkey
Nov-22-16 05:59PM  Final Trade: EEM, PHM & more
09:00AM  Smart Home For The Holidays: Honeywell Offers Tips To Maximize Connected Home Technology While Enjoying The Season PR Newswire
Nov-21-16 11:12AM  3M: Not Much To Gain From A Trump World at
10:07AM  Honeywell Handheld Computers Make Picking Up Online Purchases Easier For Consumers PR Newswire
Nov-16-16 10:02AM  KBR's Subsidiary Acquires MEI Group to Expand Capabilities
09:51AM  Honeywell Handheld Computers Help